{"gene":"TCF7L1","run_date":"2026-04-28T21:42:58","timeline":{"discoveries":[{"year":2000,"finding":"Crystal structure of β-catenin bound to the β-catenin-binding domain of Tcf3 (Tcf7l1) revealed that the Tcf3-CBD forms an elongated structure with three binding modules running antiparallel to β-catenin along the positively charged groove of the armadillo repeats; structure-based mutagenesis defined three sites in β-catenin critical for Tcf3-CBD binding that are differentially involved in binding APC, cadherin, and Axin.","method":"X-ray crystallography + structure-based mutagenesis","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with mutagenesis validation","pmids":["11136974"],"is_preprint":false},{"year":2000,"finding":"Loss-of-function of zebrafish Tcf3 (headless mutant) reveals that Tcf3 functions as a transcriptional repressor of Wnt target genes and is essential for vertebrate head formation; genetic evidence places Tcf3 as a repressor downstream of Wnt signaling during anterior patterning.","method":"Zebrafish forward genetic screen, loss-of-function mutant analysis","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis in intact organism, foundational study replicated across labs","pmids":["11057671"],"is_preprint":false},{"year":2001,"finding":"Tcf3 (Tcf7l1) competes with Axin and APC for β-catenin binding, thereby inhibiting β-catenin turnover; CK1ε phosphorylates Tcf3 to stimulate its binding to β-catenin (an effect reversed by GSK3), and Tcf3 synergizes with CK1ε to inhibit β-catenin degradation; a significant fraction of Tcf3 protein is non-nuclear.","method":"Xenopus embryo extract biochemistry, competition binding assays, in vitro kinase assays","journal":"The Journal of Cell Biology","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal biochemical methods in Xenopus system","pmids":["11524435"],"is_preprint":false},{"year":2001,"finding":"All TCF/LEF family members, including Tcf3, interact with Groucho (TLE/Grg) co-repressors; 'long' Groucho family members repress Tcf-mediated transactivation via interaction with HDAC1, while Grg-5 (short form) acts as a de-repressor; redundancy in Tcf/Grg interactions is the rule within cell lines.","method":"Reporter assays, co-immunoprecipitation, expression profiling of cell lines","journal":"Nucleic Acids Research","confidence":"High","confidence_rationale":"Tier 2 — reciprocal interaction studies across all family members, replicated findings","pmids":["11266540"],"is_preprint":false},{"year":2001,"finding":"I-mfa domain proteins (I-mfa and Xenopus XIC) inhibit the DNA binding and transcriptional activity of XTcf3 in Xenopus embryos, blocking dorsal axis specification and repressing Tcf3/β-catenin-regulated target genes (siamois, Xnr3); ectopic expression of I-mfa inhibited the ability of β-catenin to activate Lef/Tcf reporter constructs.","method":"Xenopus embryo overexpression, reporter assays, ectopic axis induction assays","journal":"Molecular and Cellular Biology","confidence":"Medium","confidence_rationale":"Tier 2 — functional assays in embryo with reporter validation, single lab","pmids":["11238923"],"is_preprint":false},{"year":2002,"finding":"In Xenopus development, XTcf-3 function is specifically required for early maternal Wnt signaling to establish the dorsal embryonic axis, while closely related XLef-1 mediates zygotic Wnt signaling to pattern the mesoderm; this demonstrates that different Lef/Tcf family members mediate tissue-specific Wnt responses in the same pathway.","method":"Xenopus loss-of-function (dominant negative constructs, morpholinos), gain-of-function, embryological assays","journal":"Current Biology","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis in Xenopus, orthogonal approaches","pmids":["12445388"],"is_preprint":false},{"year":2002,"finding":"Tcf3 binds directly to a distal TCF binding site in the Xenopus myf-5 regulatory region and represses myf-5 transcription in midline mesoderm; endogenous Wnt signaling in lateral mesoderm is required to overcome this Tcf3-mediated long-range repression.","method":"Transgenic reporter assay, in vitro DNA binding (gel shift), Xenopus embryo analysis","journal":"Mechanisms of Development","confidence":"Medium","confidence_rationale":"Tier 2 — direct DNA binding demonstrated in vitro and functional consequence shown in vivo","pmids":["12049769"],"is_preprint":false},{"year":2006,"finding":"Tcf3 directly binds to the Nanog gene promoter regulatory region and represses its transcriptional activity in embryonic stem cells through a Groucho interaction domain-dependent process; absence of Tcf3 elevates Nanog mRNA, protein and promoter activity and delays differentiation.","method":"Chromatin immunoprecipitation, promoter reporter assays, Tcf3 knockout ESCs","journal":"Molecular and Cellular Biology","confidence":"High","confidence_rationale":"Tier 2 — ChIP plus reporter assays with knockout validation, moderate-strong evidence","pmids":["16894029"],"is_preprint":false},{"year":2006,"finding":"In adult skin, Tcf3 maintains an undifferentiated stem cell state by repressing transcriptional regulators of epidermal, sebaceous gland, and hair follicle differentiation programs; upon Wnt signaling, Tcf3-expressing stem cells are directed along the hair lineage. Inducible Tcf3 reactivation in committed epidermal cells induces genes associated with an undifferentiated, Wnt-inhibited state.","method":"Inducible transgenic mouse system, gain- and loss-of-function in vivo","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 — in vivo conditional transgenic with defined phenotypic readouts, highly cited","pmids":["17018284"],"is_preprint":false},{"year":2008,"finding":"Tcf3 acts broadly on a genome-wide scale in ESCs to reduce levels of multiple self-renewal promoters (Nanog, Tcl1, Tbx3, Esrrb) while not affecting Oct4 or Sox2; Tcf3 counteracts effects of both Nanog and Oct4, functioning as a cell-intrinsic inhibitor of pluripotent cell self-renewal.","method":"Genome-wide ChIP, transcriptome analysis, Tcf3 knockout ESCs, knockdown comparisons","journal":"Stem Cells","confidence":"High","confidence_rationale":"Tier 2 — genome-wide ChIP plus transcriptomics in knockout cells","pmids":["18483421"],"is_preprint":false},{"year":2009,"finding":"In zebrafish spinal cord, Tcf3 represses sox4a expression to inhibit premature neurogenesis in spinal progenitors, and regulates Dbx gene expression in intermediate progenitors; both functions are mediated independently of canonical Wnt signaling.","method":"Zebrafish loss-of-function, in situ hybridization, epistasis with Wnt pathway components","journal":"Development","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis in vivo with pathway independence demonstrated","pmids":["19176587"],"is_preprint":false},{"year":2010,"finding":"Wnt proteins stimulate TCF3 phosphorylation in gastrulating Xenopus embryos and mammalian cells; this phosphorylation involves β-catenin-mediated recruitment of HIPK2 to TCF3, culminating in dissociation of TCF3 from target gene promoters; TCF3 mutants resistant to Wnt-dependent phosphorylation act as constitutive repressors of Vent2 and Cdx4 during axis specification.","method":"Xenopus embryo phosphorylation assays, co-immunoprecipitation, ChIP, dominant-negative and phospho-resistant mutant analysis","journal":"Developmental Cell","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods, mutagenesis, epistasis, in vivo validation","pmids":["20951344"],"is_preprint":false},{"year":2011,"finding":"HIPK2 phosphorylates TCF3 (as well as LEF1 and TCF4) in response to Wnt8 stimulation in Xenopus embryos, causing dissociation of TCF3 from target promoters; upon HIPK2-mediated phosphorylation, TCF3 is replaced at target promoters by positively acting TCF1, revealing a TCF-switching mechanism for Wnt target gene activation.","method":"In vivo phosphorylation assays in Xenopus, ChIP, dominant-negative and kinase-dead HIPK2 constructs","journal":"The Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — kinase-substrate relationship with ChIP validation and TCF-switch mechanism demonstrated","pmids":["21285352"],"is_preprint":false},{"year":2011,"finding":"Tcf3 knockout ESCs show genome-wide increase in histone H3 acetylation (AcH3) and decrease in H3K9me3, establishing that Tcf3 repressor activity maintains heterochromatin marks; absence of Tcf3 dramatically enhances efficiency of somatic cell reprogramming by modifying the epigenome early in the process.","method":"Chromatin immunofluorescence, reprogramming efficiency assays, Tcf3 knockout ESCs","journal":"PNAS","confidence":"Medium","confidence_rationale":"Tier 2 — knockout with epigenomic readouts, functional reprogramming assay","pmids":["21730189"],"is_preprint":false},{"year":2011,"finding":"Tcf3 represses Wnt/β-catenin signaling in mouse neural stem cells and HEK293 cells by two independent mechanisms: competing with other Tcf/Lef family members for β-catenin binding, and competing for DNA binding at Wnt-responsive elements; simultaneous disruption of both mechanisms is required to fully relieve Tcf3 repressor activity; β-catenin/Tcf3 interaction occurs in the nucleus.","method":"Reporter assays, co-immunoprecipitation, immunofluorescence, N-terminal deletion mutant analysis","journal":"Molecular and Cellular Biochemistry","confidence":"Medium","confidence_rationale":"Tier 2-3 — multiple mechanisms defined with Co-IP and reporter assays, single lab","pmids":["22270545"],"is_preprint":false},{"year":2011,"finding":"Genetic ablation of Tcf3 in mice replaces the requirement for exogenous Wnt3a or GSK3 inhibition for ESC self-renewal, demonstrating that inhibition of Tcf3 repressor is the necessary downstream effect of Wnt signaling; Tcf3-β-catenin and Tcf1-β-catenin interactions both contribute to Wnt stimulation, and the combination of Tcf3 and Tcf1 recruits Wnt-stabilized β-catenin to Oct4 binding sites on ESC chromatin.","method":"Tcf3 genetic knockout, Wnt3a treatment, ChIP, ESC self-renewal assays","journal":"Nature Cell Biology","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with ChIP, defines mechanistic link between Wnt and Oct4 network","pmids":["21685894"],"is_preprint":false},{"year":2011,"finding":"In zebrafish embryos, Tcf3 suppresses cdx4 expression by direct binding to multiple sites in the cdx4 gene regulatory region; Tcf3 requires Groucho/TLE and HDAC1 corepressors for activity; the transcription factor E4f1 derepresses cdx4 by dissociating corepressors from Tcf3 without inhibiting its DNA binding; E3 ubiquitin ligase Lnx2b counteracts E4f1 effects.","method":"ChIP, reporter assays, co-immunoprecipitation, zebrafish embryo gain/loss-of-function","journal":"The EMBO Journal","confidence":"High","confidence_rationale":"Tier 2 — direct DNA binding, corepressor dissociation mechanism, multiple orthogonal methods","pmids":["21666599"],"is_preprint":false},{"year":2011,"finding":"In the developing mouse neocortex, Tcf3 is expressed in undifferentiated neural progenitor cells (NPCs), functions as a repressor of Wnt signaling, binds to the Neurogenin1 promoter to repress its expression, and thereby inhibits neuronal differentiation while increasing NPC self-renewal; Wnt stimulation reduces Tcf3 levels and increases Tcf1 and Lef1, constituting a positive feedback loop that facilitates neuronal differentiation.","method":"Reporter gene assay, ChIP, gain/loss-of-function in primary NPCs, in vivo mouse analysis","journal":"PLoS One","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP with reporter assay and in vivo validation","pmids":["24832538"],"is_preprint":false},{"year":2011,"finding":"HESX1 and Tcf3 interact synergistically in a gene dosage-dependent manner to maintain anterior forebrain identity during mouse embryogenesis; Tcf3 is essential within neural ectoderm to maintain anterior character and repress Wnt/β-catenin targets; conditional deletion of β-catenin in the developing anterior forebrain of Hesx1-deficient embryos significantly rescues forebrain defects.","method":"Conditional knockout mouse genetics, zebrafish morpholino sensitized background, transcriptional profiling","journal":"Development","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis in mouse and zebrafish, rescue experiment","pmids":["22007134"],"is_preprint":false},{"year":2012,"finding":"Mouse embryos homozygous for a Tcf3ΔN knock-in mutation (ablating Tcf3-β-catenin interaction) progress through gastrulation without defect, genetically proving that Tcf3 function during gastrulation is β-catenin-independent; post-gastrulation defects in Tcf3ΔN/ΔN mice reveal that Tcf3-β-catenin indirectly activates target genes by relieving Tcf3 repression of Lef1, which then activates targets via Lef1-β-catenin complexes.","method":"Knock-in mouse genetics, epistasis analysis, in vivo developmental phenotyping","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 — clean separation-of-function knock-in with in vivo epistasis, strong genetic evidence","pmids":["22573616"],"is_preprint":false},{"year":2012,"finding":"Esrrb is a pivotal target repressed by Tcf3 downstream of Gsk3 inhibition in ESCs; Esrrb knockdown/knockout eliminates response to Gsk3 inhibition; forced Esrrb expression phenocopies Gsk3 inhibition or Tcf3 deletion by suppressing differentiation and sustaining self-renewal, establishing Esrrb as necessary and sufficient to mediate self-renewal downstream of the Gsk3/Tcf3 axis.","method":"Genome localization analysis, transcriptome analysis, knockdown, knockout, forced expression assays in ESCs","journal":"Cell Stem Cell","confidence":"High","confidence_rationale":"Tier 2 — convergent genomic and functional data, necessity and sufficiency demonstrated","pmids":["23040478"],"is_preprint":false},{"year":2013,"finding":"β-catenin inactivates Tcf7l1 (Tcf3) not by switching it to a coactivator complex but by removing it from DNA, which leads to Tcf7l1 protein degradation; mouse genetic experiments demonstrate that Tcf7l1 inactivation is the only required effect of the Tcf7l1-β-catenin interaction.","method":"Mouse genetics (knock-in alleles), ChIP, protein stability assays, breast cancer xenograft models","journal":"Cell Reports","confidence":"High","confidence_rationale":"Tier 2 — genetic experiments plus ChIP and protein degradation assays, mechanistically novel finding","pmids":["23810553"],"is_preprint":false},{"year":2013,"finding":"Tcf7l1 is necessary in pluripotent cells for lineage specification to occur concomitantly with gastrulation; in Tcf7l1−/− embryos, mesoderm specification is delayed and uncoupled from primitive streak induction; Tcf7l1 repressor activity enables a rapid switch in pluripotent cell response to Wnt/β-catenin from self-renewal to mesoderm specification.","method":"Tcf7l1 knockout mouse embryo analysis, conditional genetics, gene expression profiling","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 — knockout with defined developmental phenotype and mechanistic interpretation","pmids":["23487311"],"is_preprint":false},{"year":2013,"finding":"Wnt signaling down-regulates Tcf3 expression through decreased activating histone marks (H3K4me3, H3-acetylation) and upregulation of miR-211 (a novel Wnt-regulated microRNA targeting Tcf3); Tcf3 down-regulation is a primary response to Wnt activation (via APC mutation) and is necessary for Wnt-mediated suppression of neural differentiation in ESCs.","method":"ChIP-seq, miRNA overexpression, APC-mutant ESC lines with varying Wnt levels, rescue experiments","journal":"PLoS Genetics","confidence":"Medium","confidence_rationale":"Tier 2 — multiple epigenomic and functional approaches, single lab","pmids":["23658527"],"is_preprint":false},{"year":2013,"finding":"In granulosa cells, TCF3 is constitutively associated with the Lhcgr promoter; PKA-dependent phosphorylation of β-catenin on Ser552/Ser665 recruits it to the Lhcgr promoter together with SF1 upon FSH stimulation; dominant-negative TCF abolished FSH-induced Lhcgr reporter activity.","method":"Chromatin immunoprecipitation, adenoviral dominant-negative TCF, luciferase reporter assays, microarray","journal":"Molecular Endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP with functional reporter validation, defined promoter occupancy","pmids":["23754802"],"is_preprint":false},{"year":2014,"finding":"Tcf3 is upregulated in skin wounds; overexpression accelerates keratinocyte migration and wound healing; Stat3 is an upstream regulator of Tcf3; the pro-migration effects of Tcf3 are non-cell autonomous and β-catenin-independent; lipocalin-2 (LCN2) is the key secreted factor downstream of Tcf3 that promotes cell migration in vitro and wound healing in vivo.","method":"Gain/loss-of-function in keratinocytes and mouse wound healing models, pathway analysis, secretome studies","journal":"Nature Communications","confidence":"High","confidence_rationale":"Tier 2 — in vitro and in vivo validation with defined downstream effector and upstream regulator","pmids":["24909826"],"is_preprint":false},{"year":2014,"finding":"In zebrafish, in medaka, and in mammalian cells, Tcf3 repressor function depends critically on co-repressor interactions with Groucho/TLE proteins; inactivation of Groucho/Tle genes phenocopies tcf3 knockdown in anterior/eye development; Tcf3 function in eye development requires Groucho/Tle co-repressors.","method":"PNA-mediated knockdown in medaka, dominant-negative co-repressor approach, phenotypic analysis","journal":"BMC Biotechnology","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo loss-of-function with co-repressor dependency established","pmids":["29316906"],"is_preprint":false},{"year":2015,"finding":"Jmjd6 interacts with Tcf7l1 at the region responsible for Groucho interaction, thereby displacing the Groucho transcriptional corepressor from Tcf7l1 and derepressing Tcf7l1 target genes; Jmjd6 antagonizes Tcf7l1-mediated repression and enhances β-catenin-induced gene activation; loss of Jmjd6 causes anteroposterior axis defects in Xenopus.","method":"Co-immunoprecipitation, reporter assays, Xenopus loss-of-function, competition binding","journal":"The Journal of Biological Chemistry","confidence":"Medium","confidence_rationale":"Tier 2-3 — co-IP with functional reporter and in vivo validation, single lab","pmids":["26157142"],"is_preprint":false},{"year":2015,"finding":"Downstream of GSK3 inhibition, elevated cMyc and β-catenin act in parallel to reduce TCF7l1 levels: cMyc reduces Tcf7l1 mRNA, while β-catenin reduces Tcf7l1 DNA binding and promotes protein turnover; deletion of Tcf7l1 is sufficient to allow upregulation of FoxA2 (pioneer factor for endoderm) in the presence of Activin, identifying a cMyc/β-catenin-Tcf7l1-FoxA2 de-repression axis for endoderm induction.","method":"ESC differentiation assays, Tcf7l1 deletion, ChIP, epistasis experiments","journal":"The EMBO Journal","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis with mechanistic dissection of parallel inputs","pmids":["26675138"],"is_preprint":false},{"year":2015,"finding":"TCF3 (Tcf7l1) binds the MYC 3' WRE to repress MYC in colorectal cancer cells; depletion of TCF3 increases availability of the MYC WRE to TCF4/β-catenin complexes; GSK3β inhibition causes an exchange of TCF3 with TCF4/β-catenin at the MYC WRE to activate MYC; this TCF factor switch controls MYC expression as quiescent cells re-enter the cell cycle.","method":"ChIP, shRNA knockdown, GSK3β inhibition, cell cycle analysis","journal":"Cell Cycle","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP with functional validation of TCF exchange mechanism","pmids":["25659031"],"is_preprint":false},{"year":2016,"finding":"TCF7L1 loss in HCT116 colorectal cancer cells impaired growth and colony formation and reduced tumor growth in xenograft; TCF7L1 buffers CTNNB1/TCF target gene expression and its loss activates EPHB3 (a tumor suppressor); knockdown of EPHB3 partially restores growth of TCF7L1-null cells, demonstrating that TCF7L1 represses EPHB3 to promote CRC growth.","method":"TCF7L1 knockout in CRC cells, xenograft model, transcriptome analysis, epistasis via EPHB3 knockdown","journal":"Scientific Reports","confidence":"Medium","confidence_rationale":"Tier 2 — loss-of-function with target gene identification and epistasis, in vivo validation","pmids":["27333864"],"is_preprint":false},{"year":2016,"finding":"TCF7L1 promotes skin squamous cell carcinoma tumor growth, enhances cell migration, and overrides oncogenic RAS-induced senescence independently of its interaction with β-catenin; through transcriptome profiling and gain/loss-of-function studies, LCN2 was identified as a major downstream effector of TCF7L1 driving tumor growth.","method":"Separation-of-function mutants, β-catenin-interaction-deficient TCF7L1, mouse skin carcinogenesis model, xenograft, transcriptome profiling","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 — separation-of-function mutants with in vivo validation and effector identification","pmids":["28467300"],"is_preprint":false},{"year":2016,"finding":"In human hypothalamo-pituitary (HP) axis development, TCF7L1 functions exclusively through its repressing activity (not β-catenin interaction) in the prospective hypothalamus to maintain hypothalamic signals needed for Rathke's pouch induction; two missense variants in human TCF7L1 (p.R92P, p.R400Q) found in patients with congenital hypopituitarism exhibit reduced repressing activity in vitro and in vivo.","method":"Conditional mouse knockout, human patient variant analysis, in vitro and in vivo repression assays","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 2 — conditional genetics with human disease variant functional validation","pmids":["26764381"],"is_preprint":false},{"year":2017,"finding":"MEK inhibition suppresses LEF1 expression in mouse ESCs; knockdown/knockout of Lef1 partially mimics MEK inhibitor self-renewal effects; depletion of both Tcf3 and Lef1 enables maintenance of undifferentiated mouse ESCs without exogenous factors, demonstrating their combined role as differentiation drivers.","method":"Lef1 knockout/knockdown, MEK inhibition, transcriptome sequencing, ESC self-renewal assays","journal":"Biology Open","confidence":"Medium","confidence_rationale":"Tier 2 — double knockout with defined phenotype, single lab","pmids":["28288968"],"is_preprint":false},{"year":2019,"finding":"TCF3 (Tcf7l1) sanctions rewiring of the naive ESC gene regulatory network by suppressing components of the ESC transcription factor circuitry; triple deletion of Etv5, Rbpj, and Tcf3 locks ESCs in self-renewal even under differentiation stimuli, demonstrating complementary roles for these three repressors as drivers of the naive-to-formative pluripotency transition.","method":"Triple gene deletion, genome-wide transcriptomics, ESC differentiation assays","journal":"Cell Stem Cell","confidence":"High","confidence_rationale":"Tier 2 — combinatorial genetic epistasis with genome-wide readouts","pmids":["31031137"],"is_preprint":false},{"year":2019,"finding":"In liver cancer stem cells, Tcf7l1 suppresses self-renewal through transcriptional repression of the Nanog gene independently of β-catenin; IGF signaling stimulates Tcf7l1 phosphorylation and degradation through the MEK/ERK pathway, providing a mechanism by which extracellular signals modulate Tcf7l1 protein stability.","method":"Ectopic expression, shRNA knockdown, in vitro kinase/phosphorylation assays, tumor sphere assays","journal":"Stem Cells","confidence":"Medium","confidence_rationale":"Tier 2-3 — phosphorylation mechanism with functional consequence, single lab","pmids":["31322782"],"is_preprint":false},{"year":2019,"finding":"TCF7L1 in prostate cancer cells directly binds regulatory sequences of IL-8 and CXCR2 upon WNT4 activation to upregulate IL-8/CXCR2 signaling, driving neuroendocrine differentiation and cell motility; ADT-induced WNT4 secretion upregulates TCF7L1 in prostate cancer cells.","method":"ChIP, gene knockdown/overexpression, cytokine/receptor expression assays, prostate tissue analysis","journal":"Oncogenesis","confidence":"Medium","confidence_rationale":"Tier 2-3 — ChIP with functional validation, single lab","pmids":["34799554"],"is_preprint":false},{"year":2023,"finding":"TCF7L1 transcriptional repression promotes primitive endoderm (PE) differentiation of mESCs and in the preimplantation inner cell mass; time-series RNA sequencing and ChIP data reveal that TCF7L1 binds and represses genes encoding naive pluripotency factors and regulators of formative pluripotency including Otx2 and Lef1; TCF7L1 deletion abrogates PE differentiation without restraining epiblast priming.","method":"RNA sequencing time-series, ChIP, Tcf7l1 conditional knockout, ESC lineage differentiation assays","journal":"Nature Communications","confidence":"High","confidence_rationale":"Tier 2 — convergent genomic and genetic evidence with in vivo preimplantation validation","pmids":["36869101"],"is_preprint":false},{"year":2024,"finding":"Id2 binds Tcf3 through its HLH domain and disrupts assembly of the Tcf3-Tal1 transcriptional regulatory complex; this prevents Tcf3 interaction with histone demethylase LSD1, increasing permissive H3K4me2 at the Slamf6 promoter and epigenetically promoting generation of Slamf6+ progenitor exhausted CD8+ T cells; LSD1 inhibition rescues the Id2 knockout phenotype.","method":"Co-immunoprecipitation, ChIP-seq, ATAC-seq, Id2 knockout, LSD1 inhibitor treatment","journal":"Cellular & Molecular Immunology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal epigenomic methods with genetic and pharmacological validation","pmids":["38287103"],"is_preprint":false},{"year":2024,"finding":"Motif analysis of enhancers in mouse oocytes and early embryos identified TCF3 and TCF12 as crucial regulators of oogenesis; deficiency of TCF3 (and TCF12) impairs activation of key oocyte genes and folliculogenesis in mice.","method":"H3K27ac CUT&TAG mapping, STARR-seq reporter assay, transcription factor motif analysis, TCF3 knockout mouse phenotyping","journal":"Nature Cell Biology","confidence":"Medium","confidence_rationale":"Tier 2 — genome-wide enhancer mapping plus knockout functional validation","pmids":["38839978"],"is_preprint":false},{"year":2014,"finding":"5-carboxylcytosine (5caC) modification in the CG dinucleotide of the E-box motif (CGCAG|GTG) increases binding of the Tcf3|Ascl1 bHLH heterodimer approximately 10-fold, while not affecting other bHLH dimers tested with other cytosine modifications.","method":"In vitro DNA binding assays with modified oligonucleotide probes, systematic comparison of cytosine modifications","journal":"Biochemical and Biophysical Research Communications","confidence":"Low","confidence_rationale":"Tier 3 — in vitro binding assay only; however note this describes TCF3/E2A bHLH, not TCF7L1 HMG-box — EXCLUDE on alias collision","pmids":["24835951"],"is_preprint":false}],"current_model":"TCF7L1 (formerly Tcf3) is an HMG-box transcriptional repressor that constitutively represses Wnt target genes and pluripotency/self-renewal factors (Nanog, Esrrb, Tbx3, Lef1, FoxA2) by recruiting Groucho/TLE-HDAC1 co-repressor complexes to target promoters; Wnt/β-catenin signaling inactivates TCF7L1 by recruiting HIPK2 to phosphorylate TCF7L1, causing its dissociation from DNA and subsequent protein degradation rather than a classical coactivator switch, with β-catenin interaction being required only for TCF7L1 removal from chromatin; TCF7L1 thereby controls the balance between pluripotency maintenance and lineage specification (mesoderm, endoderm, primitive endoderm), skin stem cell identity, neural progenitor maintenance, wound repair via LCN2 secretion, and neuroendocrine differentiation in prostate cancer through direct binding to target gene promoters in a β-catenin-independent repressor mode."},"narrative":{"teleology":[{"year":2000,"claim":"Structural resolution of the β-catenin–TCF7L1 interface established the atomic basis for how TCF7L1 engages the Wnt effector β-catenin through an elongated binding domain occupying the armadillo repeat groove, revealing shared and competing binding sites with APC, Axin, and cadherins.","evidence":"X-ray crystallography of β-catenin bound to the TCF7L1 catenin-binding domain, with structure-based mutagenesis","pmids":["11136974"],"confidence":"High","gaps":["Structure did not resolve the HMG-box DNA-binding domain or full-length protein","No information on how post-translational modifications alter the interaction interface"]},{"year":2000,"claim":"The zebrafish headless mutant demonstrated that TCF7L1 functions in vivo as a transcriptional repressor of Wnt target genes essential for vertebrate head formation, establishing its identity as a default repressor rather than an activator in the Wnt pathway.","evidence":"Zebrafish forward genetic screen and loss-of-function mutant phenotyping","pmids":["11057671"],"confidence":"High","gaps":["Downstream target genes were not individually identified","Whether repression was Groucho-dependent was not tested"]},{"year":2001,"claim":"Biochemical studies revealed that TCF7L1 competes with Axin/APC for β-catenin binding and that CK1ε phosphorylation stimulates this interaction, while identification of Groucho/TLE–HDAC1 as obligate co-repressors defined the molecular machinery through which TCF7L1 silences target genes.","evidence":"Xenopus extract competition binding assays, in vitro kinase assays, co-immunoprecipitation and reporter assays across TCF/LEF family members","pmids":["11524435","11266540"],"confidence":"High","gaps":["Endogenous chromatin occupancy was not assessed","Relative contributions of CK1ε versus other kinases in vivo were unclear"]},{"year":2006,"claim":"ChIP and knockout studies in embryonic stem cells and adult skin established that TCF7L1 directly binds and represses the Nanog promoter and maintains an undifferentiated stem cell state by silencing differentiation programs in a Groucho-interaction-domain-dependent manner.","evidence":"Chromatin immunoprecipitation, promoter reporter assays, Tcf3 knockout ESCs, inducible transgenic mouse skin system","pmids":["16894029","17018284"],"confidence":"High","gaps":["Genome-wide target repertoire was not yet mapped","How Wnt signaling quantitatively tunes TCF7L1 occupancy at Nanog was unresolved"]},{"year":2008,"claim":"Genome-wide ChIP and transcriptomics in ESCs demonstrated that TCF7L1 acts broadly to repress multiple self-renewal genes (Nanog, Tcl1, Tbx3, Esrrb) without affecting Oct4 or Sox2, redefining it as a cell-intrinsic inhibitor of the entire pluripotency network rather than a single-gene repressor.","evidence":"Genome-wide ChIP-chip and transcriptome analysis in Tcf3 knockout ESCs","pmids":["18483421"],"confidence":"High","gaps":["Whether TCF7L1 directly or indirectly repressed each target was not fully resolved","Epigenomic consequences of TCF7L1 binding were not characterized"]},{"year":2010,"claim":"The discovery that Wnt-stimulated β-catenin recruits HIPK2 to phosphorylate TCF7L1, causing its dissociation from DNA, overturned the classical coactivator-switch model and established a 'removal' mechanism as the primary mode of TCF7L1 inactivation during Wnt signaling.","evidence":"Xenopus embryo phosphorylation assays, co-immunoprecipitation, ChIP, phospho-resistant mutant analysis","pmids":["20951344"],"confidence":"High","gaps":["Specific HIPK2 phosphorylation sites on TCF7L1 were not mapped","Whether HIPK2-mediated removal operates in all cell types was untested"]},{"year":2011,"claim":"A convergence of studies established the TCF-switching paradigm: HIPK2-mediated TCF7L1 phosphorylation causes its replacement by activating TCF1 at target promoters; genetic ablation of Tcf3 replaced the requirement for Wnt3a in ESC self-renewal; and Groucho/TLE–HDAC1 co-repressors were shown to be essential for TCF7L1 repression at targets like cdx4, with E4f1 capable of displacing co-repressors without affecting DNA binding.","evidence":"HIPK2 kinase-dead constructs and ChIP in Xenopus; Tcf3 genetic knockout with ChIP in ESCs; zebrafish co-repressor epistasis","pmids":["21285352","21685894","21666599"],"confidence":"High","gaps":["How TCF1 is selectively recruited to vacated sites was mechanistically unclear","Whether the TCF switch requires additional chromatin remodeling factors was not addressed"]},{"year":2011,"claim":"Tcf3 knockout ESCs showed genome-wide increases in H3 acetylation and decreases in H3K9me3, revealing that TCF7L1 repression maintains heterochromatin marks and explaining how its absence dramatically enhances somatic cell reprogramming efficiency.","evidence":"Chromatin immunofluorescence and reprogramming assays in Tcf3 knockout ESCs","pmids":["21730189"],"confidence":"Medium","gaps":["Whether epigenomic changes are direct consequences of TCF7L1 binding or secondary effects was not resolved","Genome-wide ChIP-seq for histone marks in knockout cells was not performed"]},{"year":2012,"claim":"A β-catenin-interaction-deficient knock-in mouse (Tcf3ΔN) progressed through gastrulation normally, genetically proving that TCF7L1's primary repressor function during gastrulation is β-catenin-independent; post-gastrulation, β-catenin interaction indirectly activates targets by de-repressing Lef1, which then activates genes via Lef1–β-catenin complexes.","evidence":"Knock-in mouse genetics with developmental phenotyping and epistasis analysis","pmids":["22573616"],"confidence":"High","gaps":["How TCF7L1 represses Lef1 mechanistically (direct binding versus indirect) was not dissected at the chromatin level","Whether this indirect activation model applies to all post-gastrulation contexts was unknown"]},{"year":2012,"claim":"Identification of Esrrb as the pivotal target repressed by TCF7L1 downstream of GSK3 inhibition, where forced Esrrb expression is sufficient to replace GSK3 inhibition or Tcf3 deletion for ESC self-renewal, defined the minimal effector axis linking Wnt signaling to pluripotency maintenance.","evidence":"Genome localization, transcriptome analysis, knockdown/knockout and forced expression in ESCs","pmids":["23040478"],"confidence":"High","gaps":["Whether Esrrb sufficiency extends to in vivo contexts was not tested","Other TCF7L1 targets may contribute to self-renewal in parallel"]},{"year":2013,"claim":"β-catenin was shown to inactivate TCF7L1 by promoting its removal from DNA and subsequent protein degradation rather than by forming a coactivator complex, with mouse genetics demonstrating that TCF7L1 inactivation is the sole required output of the TCF7L1–β-catenin interaction.","evidence":"Mouse knock-in alleles, ChIP, protein stability assays","pmids":["23810553"],"confidence":"High","gaps":["The ubiquitin ligase responsible for TCF7L1 degradation was not identified","Whether degradation is proteasome-dependent was not directly shown"]},{"year":2014,"claim":"TCF7L1 was found to promote wound healing via a β-catenin-independent, non-cell-autonomous mechanism in skin keratinocytes, with LCN2 identified as the secreted effector and Stat3 as an upstream activator, revealing a Wnt-independent wound repair function.","evidence":"Gain/loss-of-function in keratinocytes and mouse wound healing models, secretome analysis","pmids":["24909826"],"confidence":"High","gaps":["How TCF7L1 transcriptionally activates LCN2 (direct binding versus indirect) was not established","Whether this pathway operates in non-cutaneous wound repair was unknown"]},{"year":2016,"claim":"Human TCF7L1 variants (p.R92P, p.R400Q) with reduced repressor activity were identified in patients with congenital hypopituitarism, and conditional mouse knockouts confirmed that TCF7L1 repressor function in the prospective hypothalamus is essential for Rathke's pouch induction independently of β-catenin interaction.","evidence":"Conditional mouse knockout, human patient variant identification and functional validation in vitro and in vivo","pmids":["26764381"],"confidence":"High","gaps":["Penetrance and expressivity of TCF7L1 variants in larger patient cohorts was not assessed","Precise target genes repressed by TCF7L1 in hypothalamic development were not identified"]},{"year":2019,"claim":"Triple deletion of Etv5, Rbpj, and Tcf3 locked ESCs in self-renewal under differentiation conditions, demonstrating that TCF7L1 functions alongside FGF- and Notch-pathway repressors as a driver of the naive-to-formative pluripotency transition.","evidence":"Triple gene deletion with genome-wide transcriptomics and ESC differentiation assays","pmids":["31031137"],"confidence":"High","gaps":["Whether these three factors converge on shared target genes or act in parallel was not resolved","The formative state was defined transcriptomically but not functionally in vivo"]},{"year":2023,"claim":"Time-series genomics established that TCF7L1 transcriptional repression promotes primitive endoderm differentiation by directly repressing naive pluripotency factors and formative regulators including Otx2 and Lef1, while its deletion specifically abrogates primitive endoderm without restraining epiblast priming.","evidence":"RNA-seq time-series, ChIP, Tcf7l1 conditional knockout, ESC differentiation and preimplantation embryo analysis","pmids":["36869101"],"confidence":"High","gaps":["Whether TCF7L1 represses distinct target sets in primitive endoderm versus epiblast lineages was not fully dissected","Upstream signals that modulate TCF7L1 occupancy during preimplantation were not identified"]},{"year":2024,"claim":"In CD8+ T cells, Id2 disrupts a TCF7L1–Tal1–LSD1 complex at the Slamf6 promoter, preventing LSD1-mediated H3K4me2 demethylation and epigenetically promoting progenitor exhausted T cell fate, revealing a TCF7L1 repressor function in adaptive immunity.","evidence":"Co-immunoprecipitation, ChIP-seq, ATAC-seq, Id2 knockout with LSD1 inhibitor rescue","pmids":["38287103"],"confidence":"High","gaps":["Whether TCF7L1 partners with LSD1 at other immune gene loci is unknown","The generality of TCF7L1 function in T cell biology beyond the exhaustion context has not been explored"]},{"year":null,"claim":"The ubiquitin ligase(s) responsible for TCF7L1 degradation upon Wnt-stimulated removal from DNA, the full structural basis of the HMG-box domain on chromatin, and whether the TCF-switching mechanism operates uniformly across all TCF7L1-expressing tissues remain unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No E3 ligase for TCF7L1 turnover has been identified","No full-length TCF7L1 structure exists","Tissue-specific modulation of the TCF switch is uncharacterized"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,6,7,9,16,24,29,36,37]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[1,7,8,9,15,16,17,19,20,21,22,28,30,31,32,34,37]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[2,14,29]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[7,9,14,15,16,24,37,38]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[7,9,16,17,20,22,28,30,34,37]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[1,5,8,18,19,22,32,39]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[13,38]}],"complexes":["Groucho/TLE-HDAC1 co-repressor complex","TCF7L1–β-catenin complex","TCF7L1–Tal1–LSD1 complex"],"partners":["CTNNB1","TLE1","HDAC1","HIPK2","JMJD6","E4F1","TAL1","LSD1"],"other_free_text":[]},"mechanistic_narrative":"TCF7L1 (formerly Tcf3) is an HMG-box transcription factor that functions as a constitutive repressor of Wnt target genes and pluripotency regulators, thereby governing the balance between stem cell self-renewal and lineage specification across multiple tissues. TCF7L1 represses target genes—including Nanog, Esrrb, Tbx3, Lef1, FoxA2, and Neurogenin1—by recruiting Groucho/TLE–HDAC1 co-repressor complexes to their promoters, and this repression maintains heterochromatin marks (reduced H3 acetylation, elevated H3K9me3) genome-wide [PMID:16894029, PMID:18483421, PMID:21666599, PMID:21730189]. Wnt/β-catenin signaling inactivates TCF7L1 not by converting it into a coactivator but by recruiting HIPK2 to phosphorylate TCF7L1, causing its dissociation from DNA and subsequent protein degradation, which enables replacement by positively acting TCF1/LEF1 at target promoters [PMID:20951344, PMID:21285352, PMID:23810553]. Missense variants in TCF7L1 with reduced repressor activity have been identified in patients with congenital hypopituitarism, establishing a direct link between impaired TCF7L1 repression and human hypothalamo-pituitary developmental disease [PMID:26764381]."},"prefetch_data":{"uniprot":{"accession":"Q9HCS4","full_name":"Transcription factor 7-like 1","aliases":["HMG box transcription factor 3","TCF-3"],"length_aa":588,"mass_kda":62.6,"function":"Participates in the Wnt signaling pathway. Binds to DNA and acts as a repressor in the absence of CTNNB1, and as an activator in its presence. Necessary for the terminal differentiation of epidermal cells, the formation of keratohyalin granules and the development of the barrier function of the epidermis (By similarity). Down-regulates NQO1, leading to increased mitomycin c resistance","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9HCS4/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TCF7L1","classification":"Not Classified","n_dependent_lines":15,"n_total_lines":1208,"dependency_fraction":0.012417218543046357},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/TCF7L1","total_profiled":1310},"omim":[{"mim_id":"604652","title":"TRANSCRIPTION FACTOR 7-LIKE 1; TCF7L1","url":"https://www.omim.org/entry/604652"},{"mim_id":"602228","title":"TRANSCRIPTION FACTOR 7-LIKE 2; TCF7L2","url":"https://www.omim.org/entry/602228"},{"mim_id":"147141","title":"TRANSCRIPTION FACTOR 3; TCF3","url":"https://www.omim.org/entry/147141"},{"mim_id":"114500","title":"COLORECTAL CANCER; CRC","url":"https://www.omim.org/entry/114500"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/TCF7L1"},"hgnc":{"alias_symbol":[],"prev_symbol":["TCF3"]},"alphafold":{"accession":"Q9HCS4","domains":[{"cath_id":"1.10.30.10","chopping":"348-415","consensus_level":"medium","plddt":92.5981,"start":348,"end":415}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9HCS4","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9HCS4-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9HCS4-F1-predicted_aligned_error_v6.png","plddt_mean":51.78},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TCF7L1","jax_strain_url":"https://www.jax.org/strain/search?query=TCF7L1"},"sequence":{"accession":"Q9HCS4","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9HCS4.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9HCS4/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9HCS4"}},"corpus_meta":[{"pmid":"16510593","id":"PMC_16510593","title":"Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B.","date":"2006","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/16510593","citation_count":357,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11057671","id":"PMC_11057671","title":"Repressor activity of Headless/Tcf3 is essential for vertebrate head formation.","date":"2000","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/11057671","citation_count":327,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23040478","id":"PMC_23040478","title":"Esrrb is a pivotal target of the Gsk3/Tcf3 axis regulating embryonic stem cell self-renewal.","date":"2012","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/23040478","citation_count":320,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21685894","id":"PMC_21685894","title":"Opposing effects of Tcf3 and Tcf1 control Wnt stimulation of embryonic stem cell self-renewal.","date":"2011","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/21685894","citation_count":252,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16894029","id":"PMC_16894029","title":"Repression of Nanog gene transcription by Tcf3 limits embryonic stem cell self-renewal.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16894029","citation_count":249,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17018284","id":"PMC_17018284","title":"Tcf3 governs stem cell features and represses cell fate determination in skin.","date":"2006","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/17018284","citation_count":245,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20951344","id":"PMC_20951344","title":"Regulation of TCF3 by Wnt-dependent phosphorylation during vertebrate axis specification.","date":"2010","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/20951344","citation_count":132,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18483421","id":"PMC_18483421","title":"Tcf3 functions as a steady-state limiter of transcriptional programs of mouse embryonic stem cell self-renewal.","date":"2008","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/18483421","citation_count":129,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11524435","id":"PMC_11524435","title":"Physiological regulation of [beta]-catenin stability by Tcf3 and CK1epsilon.","date":"2001","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11524435","citation_count":126,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11085512","id":"PMC_11085512","title":"Mitomycin C resistance induced by TCF-3 overexpression in gastric cancer cell line MKN28 is associated with DT-diaphorase down-regulation.","date":"2000","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/11085512","citation_count":118,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19282835","id":"PMC_19282835","title":"Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)/TCF3-PBX1.","date":"2009","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/19282835","citation_count":109,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23810553","id":"PMC_23810553","title":"Regulation of Tcf7l1 DNA binding and protein stability as principal mechanisms of Wnt/β-catenin signaling.","date":"2013","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/23810553","citation_count":98,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22573616","id":"PMC_22573616","title":"Function of Wnt/β-catenin in counteracting Tcf3 repression through the Tcf3-β-catenin interaction.","date":"2012","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/22573616","citation_count":91,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31031137","id":"PMC_31031137","title":"Complementary Activity of ETV5, RBPJ, and TCF3 Drives Formative Transition from Naive Pluripotency.","date":"2019","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/31031137","citation_count":82,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29797659","id":"PMC_29797659","title":"Myeloid lineage switch following chimeric antigen receptor T-cell therapy in a patient with TCF3-ZNF384 fusion-positive B-lymphoblastic leukemia.","date":"2018","source":"Pediatric blood & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/29797659","citation_count":76,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23090119","id":"PMC_23090119","title":"Control of breast cancer growth and initiation by the stem cell-associated transcription factor TCF3.","date":"2012","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/23090119","citation_count":71,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24909826","id":"PMC_24909826","title":"Tcf3 promotes cell migration and wound repair through regulation of lipocalin 2.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/24909826","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23658527","id":"PMC_23658527","title":"Wnt signaling regulates the lineage differentiation potential of mouse embryonic stem cells through Tcf3 down-regulation.","date":"2013","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23658527","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24920014","id":"PMC_24920014","title":"A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/24920014","citation_count":65,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9784608","id":"PMC_9784608","title":"Function of zebrafish beta-catenin and TCF-3 in dorsoventral patterning.","date":"1998","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/9784608","citation_count":62,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30115631","id":"PMC_30115631","title":"TCF3 alternative splicing controlled by hnRNP H/F regulates E-cadherin expression and hESC pluripotency.","date":"2018","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/30115631","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23754802","id":"PMC_23754802","title":"Lhcgr expression in granulosa cells: roles for PKA-phosphorylated β-catenin, TCF3, and FOXO1.","date":"2013","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/23754802","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23684607","id":"PMC_23684607","title":"A genetic screen identifies TCF3/E2A and TRIAP1 as pathway-specific regulators of the cellular response to p53 activation.","date":"2013","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/23684607","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30778199","id":"PMC_30778199","title":"HN1L-mediated transcriptional axis AP-2γ/METTL13/TCF3-ZEB1 drives tumor growth and metastasis in hepatocellular carcinoma.","date":"2019","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/30778199","citation_count":59,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23487311","id":"PMC_23487311","title":"Tcf7l1 prepares epiblast cells in the gastrulating mouse embryo for lineage specification.","date":"2013","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/23487311","citation_count":58,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24832538","id":"PMC_24832538","title":"Tcf3 represses Wnt-β-catenin signaling and maintains neural stem cell population during neocortical development.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24832538","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11238923","id":"PMC_11238923","title":"Inhibition of Tcf3 binding by I-mfa domain proteins.","date":"2001","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11238923","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29114388","id":"PMC_29114388","title":"Epistatic interactions between mutations of TACI (TNFRSF13B) and TCF3 result in a severe primary immunodeficiency disorder and systemic lupus erythematosus.","date":"2017","source":"Clinical & translational immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29114388","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21730189","id":"PMC_21730189","title":"T-cell factor 3 (Tcf3) deletion increases somatic cell reprogramming by inducing epigenome modifications.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/21730189","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17311319","id":"PMC_17311319","title":"Molecular cytogenetic characterization of TCF3 (E2A)/19p13.3 rearrangements in B-cell precursor acute lymphoblastic leukemia.","date":"2007","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/17311319","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12445388","id":"PMC_12445388","title":"Lef-1 and Tcf-3 transcription factors mediate tissue-specific Wnt signaling during Xenopus development.","date":"2002","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/12445388","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27461063","id":"PMC_27461063","title":"Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia.","date":"2016","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/27461063","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31735627","id":"PMC_31735627","title":"The Leukemogenic TCF3-HLF Complex Rewires Enhancers Driving Cellular Identity and Self-Renewal Conferring EP300 Vulnerability.","date":"2019","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/31735627","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22564737","id":"PMC_22564737","title":"Increased expression of bHLH transcription factor E2A (TCF3) in prostate cancer promotes proliferation and confers resistance to doxorubicin induced apoptosis.","date":"2012","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/22564737","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30631148","id":"PMC_30631148","title":"Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting.","date":"2019","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/30631148","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25659031","id":"PMC_25659031","title":"A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells.","date":"2015","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/25659031","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28209658","id":"PMC_28209658","title":"Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols.","date":"2017","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/28209658","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22007134","id":"PMC_22007134","title":"HESX1- and TCF3-mediated repression of Wnt/β-catenin targets is required for normal development of the anterior forebrain.","date":"2011","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/22007134","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27333864","id":"PMC_27333864","title":"TCF7L1 Modulates Colorectal Cancer Growth by Inhibiting Expression of the Tumor-Suppressor Gene EPHB3.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27333864","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34175897","id":"PMC_34175897","title":"TCF3 is epigenetically silenced by EZH2 and DNMT3B and functions as a tumor suppressor in endometrial cancer.","date":"2021","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/34175897","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38839978","id":"PMC_38839978","title":"Mapping putative enhancers in mouse oocytes and early embryos reveals TCF3/12 as key folliculogenesis regulators.","date":"2024","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/38839978","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34624079","id":"PMC_34624079","title":"SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma.","date":"2022","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/34624079","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30083263","id":"PMC_30083263","title":"HSP40 co-chaperone protein Tid1 suppresses metastasis of head and neck cancer by inhibiting Galectin-7-TCF3-MMP9 axis signaling.","date":"2018","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/30083263","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34728784","id":"PMC_34728784","title":"Decreased expression of ATF3, orchestrated by β-catenin/TCF3, miR-17-5p and HOXA11-AS, promoted gastric cancer progression via increased β-catenin and CEMIP.","date":"2021","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34728784","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19176587","id":"PMC_19176587","title":"Tcf3 inhibits spinal cord neurogenesis by regulating sox4a expression.","date":"2009","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/19176587","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27538704","id":"PMC_27538704","title":"MicroRNA-506-3p regulates neural stem cell proliferation and differentiation through targeting TCF3.","date":"2016","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/27538704","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11437409","id":"PMC_11437409","title":"Tcf-3 expression and beta-catenin mediated transcriptional activation in aggressive fibromatosis (desmoid tumour).","date":"2001","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/11437409","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38287103","id":"PMC_38287103","title":"Id2 epigenetically controls CD8+ T-cell exhaustion by disrupting the assembly of the Tcf3-LSD1 complex.","date":"2024","source":"Cellular & molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/38287103","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26675138","id":"PMC_26675138","title":"Convergence of cMyc and β-catenin on Tcf7l1 enables endoderm specification.","date":"2015","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/26675138","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27894958","id":"PMC_27894958","title":"Poly (ADP-ribose) polymerase inhibitors selectively induce cytotoxicity in TCF3-HLF-positive leukemic cells.","date":"2016","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/27894958","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24578304","id":"PMC_24578304","title":"Outcome of TCF3-PBX1 positive pediatric acute lymphoblastic leukemia patients in Japan: a collaborative study of Japan Association of Childhood Leukemia Study (JACLS) and Children's Cancer and Leukemia Study Group (CCLSG).","date":"2014","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24578304","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23063976","id":"PMC_23063976","title":"Tcf3 and cell cycle factors contribute to butyrate resistance in colorectal cancer cells.","date":"2012","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/23063976","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25038042","id":"PMC_25038042","title":"Tcf3 expression marks both stem and progenitor cells in multiple epithelia.","date":"2014","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/25038042","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36869101","id":"PMC_36869101","title":"The Wnt/TCF7L1 transcriptional repressor axis drives primitive endoderm formation by antagonizing naive and formative pluripotency.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36869101","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24997151","id":"PMC_24997151","title":"The Sox4/Tcf7l1 axis promotes progression of BCR-ABL-positive acute lymphoblastic leukemia.","date":"2014","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/24997151","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25375219","id":"PMC_25375219","title":"Hypomethylation-associated up-regulation of TCF3 expression and recurrence in stage II and III colorectal cancer.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25375219","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24153013","id":"PMC_24153013","title":"Altered expression of miR-24, miR-126 and miR-365 does not affect viability of childhood TCF3-rearranged leukemia cells.","date":"2013","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/24153013","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28385388","id":"PMC_28385388","title":"MicroRNA-138 is a potential biomarker and tumor suppressor in human cervical carcinoma by reversely correlated with TCF3 gene.","date":"2017","source":"Gynecologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/28385388","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21666599","id":"PMC_21666599","title":"Modulation of Tcf3 repressor complex composition regulates cdx4 expression in zebrafish.","date":"2011","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/21666599","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32203922","id":"PMC_32203922","title":"Redox-mediated regulation of aging and healthspan by an evolutionarily conserved transcription factor HLH-2/Tcf3/E2A.","date":"2020","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/32203922","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12049769","id":"PMC_12049769","title":"Repression through a distal TCF-3 binding site restricts Xenopus myf-5 expression in gastrula mesoderm.","date":"2002","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/12049769","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28288968","id":"PMC_28288968","title":"Depletion of Tcf3 and Lef1 maintains mouse embryonic stem cell self-renewal.","date":"2017","source":"Biology open","url":"https://pubmed.ncbi.nlm.nih.gov/28288968","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28467300","id":"PMC_28467300","title":"TCF7L1 promotes skin tumorigenesis independently of β-catenin through induction of LCN2.","date":"2017","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/28467300","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30063982","id":"PMC_30063982","title":"Autosomal Recessive Agammaglobulinemia - first case with a novel TCF3 mutation from Pakistan.","date":"2018","source":"Clinical immunology (Orlando, Fla.)","url":"https://pubmed.ncbi.nlm.nih.gov/30063982","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30582201","id":"PMC_30582201","title":"DDN-AS1-miR-15a/16-TCF3 feedback loop regulates tumor progression in cervical cancer.","date":"2018","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30582201","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33011533","id":"PMC_33011533","title":"TCF3-activated FAM201A enhances cell proliferation and invasion via miR-186-5p/TNKS1BP1 axis in triple-negative breast cancer.","date":"2020","source":"Bioorganic chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33011533","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31391218","id":"PMC_31391218","title":"TCF3 mutually exclusive alternative splicing is controlled by long-range cooperative actions between hnRNPH1 and PTBP1.","date":"2019","source":"RNA (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/31391218","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23181981","id":"PMC_23181981","title":"A novel TCF3-HLF fusion transcript in acute lymphoblastic leukemia with a t(17;19)(q22;p13).","date":"2012","source":"Cancer genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23181981","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26029241","id":"PMC_26029241","title":"Sites of instability in the human TCF3 (E2A) gene adopt G-quadruplex DNA structures in vitro.","date":"2015","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26029241","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23859904","id":"PMC_23859904","title":"Frequency of the ETV6-RUNX1, BCR-ABL1, TCF3-PBX1, and MLL-AFF1 fusion genes in Guatemalan pediatric acute lymphoblastic leukemia patients and their ethnic associations.","date":"2013","source":"Cancer genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23859904","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24835951","id":"PMC_24835951","title":"Carboxylation of cytosine (5caC) in the CG dinucleotide in the E-box motif (CGCAG|GTG) increases binding of the Tcf3|Ascl1 helix-loop-helix heterodimer 10-fold.","date":"2014","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/24835951","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34422820","id":"PMC_34422820","title":"TCF3 Regulates the Proliferation and Apoptosis of Human Spermatogonial Stem Cells by Targeting PODXL.","date":"2021","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/34422820","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26807321","id":"PMC_26807321","title":"Basic helix loop helix (bHLH) transcription factor 3 (TCF3, E2A) is regulated by androgens in prostate cancer cells.","date":"2015","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/26807321","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31575852","id":"PMC_31575852","title":"Characterization of TCF3 rearrangements in pediatric B-lymphoblastic leukemia/lymphoma by mate-pair sequencing (MPseq) identifies complex genomic rearrangements and a novel TCF3/TEF gene fusion.","date":"2019","source":"Blood cancer journal","url":"https://pubmed.ncbi.nlm.nih.gov/31575852","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35239510","id":"PMC_35239510","title":"TCF3 regulates human endometrial stromal cell proliferation and migration in RPL.","date":"2022","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/35239510","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27431573","id":"PMC_27431573","title":"Regulation of the miRNA expression by TEL/AML1, BCR/ABL, MLL/AF4 and TCF3/PBX1 oncoproteins in acute lymphoblastic leukemia (Review).","date":"2016","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/27431573","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37277074","id":"PMC_37277074","title":"TCF3 haploinsufficiency defined by immune, clinical, gene-dosage, and murine studies.","date":"2023","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37277074","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31322782","id":"PMC_31322782","title":"Tcf7l1 Acts as a Suppressor for the Self-Renewal of Liver Cancer Stem Cells and Is Regulated by IGF/MEK/ERK Signaling Independent of β-Catenin.","date":"2019","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/31322782","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26157142","id":"PMC_26157142","title":"JmjC Domain-containing Protein 6 (Jmjd6) Derepresses the Transcriptional Repressor Transcription Factor 7-like 1 (Tcf7l1) and Is Required for Body Axis Patterning during Xenopus Embryogenesis.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26157142","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33640284","id":"PMC_33640284","title":"Successful Treatment of TCF3-HLF-positive Childhood B-ALL with Chimeric Antigen Receptor T-Cell Therapy.","date":"2021","source":"Clinical lymphoma, myeloma & leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/33640284","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30051646","id":"PMC_30051646","title":"Excellent outcome of acute lymphoblastic leukaemia with TCF3-PBX1 rearrangement in Hong Kong.","date":"2018","source":"Pediatric blood & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/30051646","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32449435","id":"PMC_32449435","title":"Burkitt lymphoma-related TCF3 mutations alter TCF3 alternative splicing by disrupting hnRNPH1 binding.","date":"2020","source":"RNA biology","url":"https://pubmed.ncbi.nlm.nih.gov/32449435","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32003049","id":"PMC_32003049","title":"Tcf3-activated lncRNA Gas5 regulates newborn mouse cardiomyocyte apoptosis in diabetic cardiomyopathy.","date":"2020","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32003049","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34799554","id":"PMC_34799554","title":"TCF7L1 regulates cytokine response and neuroendocrine differentiation of prostate cancer.","date":"2021","source":"Oncogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/34799554","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37867222","id":"PMC_37867222","title":"Transcription Factor Id1 Plays an Essential Role in Th9 Cell Differentiation by Inhibiting Tcf3 and Tcf4.","date":"2023","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/37867222","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31033094","id":"PMC_31033094","title":"Inhibition of transcription factor T-cell factor 3 (TCF3) using the oligodeoxynucleotide strategy increases embryonic stem cell stemness: possible application in regenerative medicine.","date":"2019","source":"Cell biology international","url":"https://pubmed.ncbi.nlm.nih.gov/31033094","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22270545","id":"PMC_22270545","title":"Mouse Tcf3 represses canonical Wnt signaling by either competing for β-catenin binding or through occupation of DNA-binding sites.","date":"2012","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22270545","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29334255","id":"PMC_29334255","title":"NGS-based methylation profiling differentiates TCF3-HLF and TCF3-PBX1 positive B-cell acute lymphoblastic leukemia.","date":"2018","source":"Epigenomics","url":"https://pubmed.ncbi.nlm.nih.gov/29334255","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30326964","id":"PMC_30326964","title":"Tcf7l1 directly regulates cardiomyocyte differentiation in embryonic stem cells.","date":"2018","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/30326964","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32882024","id":"PMC_32882024","title":"Genome-Wide Association Study of Susceptibility Loci for TCF3-PBX1 Acute Lymphoblastic Leukemia in Children.","date":"2021","source":"Journal of the National Cancer Institute","url":"https://pubmed.ncbi.nlm.nih.gov/32882024","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24135088","id":"PMC_24135088","title":"Translocation junctions in TCF3-PBX1 acute lymphoblastic leukemia/lymphoma cluster near transposable elements.","date":"2013","source":"Mobile DNA","url":"https://pubmed.ncbi.nlm.nih.gov/24135088","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36908661","id":"PMC_36908661","title":"TCF7L1 Accelerates Smooth Muscle Cell Phenotypic Switching and Aggravates Abdominal Aortic Aneurysms.","date":"2022","source":"JACC. Basic to translational science","url":"https://pubmed.ncbi.nlm.nih.gov/36908661","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32432381","id":"PMC_32432381","title":"Gene regulation could be attributed to TCF3 and other key transcription factors in the muscle of pubertal heifers.","date":"2020","source":"Veterinary medicine and science","url":"https://pubmed.ncbi.nlm.nih.gov/32432381","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31381875","id":"PMC_31381875","title":"Wnt suppressor and stem cell regulator TCF7L1 is a sensitive immunohistochemical marker to differentiate testicular seminoma from non-seminomatous germ cell tumor.","date":"2019","source":"Experimental and molecular pathology","url":"https://pubmed.ncbi.nlm.nih.gov/31381875","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29299140","id":"PMC_29299140","title":"MicroRNA-449a maintains self-renewal in liver cancer stem-like cells by targeting Tcf3.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29299140","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21932308","id":"PMC_21932308","title":"Tcf7l1 is required for spinal cord progenitor maintenance.","date":"2011","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/21932308","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34395283","id":"PMC_34395283","title":"Leukemia With TCF3-ZNF384 Rearrangement as a Distinct Subtype of Disease With Distinct Treatments: Perspectives From A Case Report and Literature Review.","date":"2021","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/34395283","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25729575","id":"PMC_25729575","title":"A (1;19) translocation involving TCF3-PBX1 fusion within the context of a hyperdiploid karyotype in adult B-ALL: a case report and review of the literature.","date":"2015","source":"Biomarker research","url":"https://pubmed.ncbi.nlm.nih.gov/25729575","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30730614","id":"PMC_30730614","title":"Flow cytometric predictive scoring systems for common fusions ETV6/RUNX1, BCR/ABL1, TCF3/PBX1 and rearrangements of the KMT2A gene, proposed for the initial cytogenetic approach in cases of B-acute lymphoblastic leukemia.","date":"2019","source":"International journal of laboratory hematology","url":"https://pubmed.ncbi.nlm.nih.gov/30730614","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29316906","id":"PMC_29316906","title":"The function of tcf3 in medaka embryos: efficient knockdown with pePNAs.","date":"2018","source":"BMC biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/29316906","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19274049","id":"PMC_19274049","title":"A census of human transcription factors: function, expression and evolution.","date":"2009","source":"Nature reviews. Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19274049","citation_count":1191,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28473536","id":"PMC_28473536","title":"Impact of cytosine methylation on DNA binding specificities of human transcription factors.","date":"2017","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/28473536","citation_count":934,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11136974","id":"PMC_11136974","title":"Crystal structure of a beta-catenin/Tcf complex.","date":"2000","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/11136974","citation_count":353,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11266540","id":"PMC_11266540","title":"All Tcf HMG box transcription factors interact with Groucho-related co-repressors.","date":"2001","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/11266540","citation_count":310,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17873379","id":"PMC_17873379","title":"Networking of WNT, FGF, Notch, BMP, and Hedgehog signaling pathways during carcinogenesis.","date":"2007","source":"Stem cell reviews","url":"https://pubmed.ncbi.nlm.nih.gov/17873379","citation_count":245,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16565489","id":"PMC_16565489","title":"Activation of the canonical wingless/T-cell factor signaling pathway promotes invasive differentiation of human trophoblast.","date":"2006","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/16565489","citation_count":162,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15327769","id":"PMC_15327769","title":"Crystal structure of a beta-catenin/APC complex reveals a critical role for APC phosphorylation in APC function.","date":"2004","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/15327769","citation_count":135,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9916915","id":"PMC_9916915","title":"Restricted high level expression of Tcf-4 protein in intestinal and mammary gland epithelium.","date":"1999","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/9916915","citation_count":131,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"31753913","id":"PMC_31753913","title":"Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.","date":"2019","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/31753913","citation_count":110,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20379614","id":"PMC_20379614","title":"Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.","date":"2010","source":"Molecular medicine (Cambridge, Mass.)","url":"https://pubmed.ncbi.nlm.nih.gov/20379614","citation_count":108,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21285352","id":"PMC_21285352","title":"Phosphorylation of TCF proteins by homeodomain-interacting protein kinase 2.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21285352","citation_count":83,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"24596249","id":"PMC_24596249","title":"Molecular functions of the TLE tetramerization domain in Wnt target gene repression.","date":"2014","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/24596249","citation_count":81,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22930747","id":"PMC_22930747","title":"Genome-wide methylation screen in low-grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis.","date":"2012","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/22930747","citation_count":77,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19308021","id":"PMC_19308021","title":"Findings from bipolar disorder genome-wide association studies replicate in a Finnish bipolar family-cohort.","date":"2009","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/19308021","citation_count":73,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19373426","id":"PMC_19373426","title":"Wnt pathway genes in osteoporosis and osteoarthritis: differential expression and genetic association study.","date":"2009","source":"Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA","url":"https://pubmed.ncbi.nlm.nih.gov/19373426","citation_count":69,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15815621","id":"PMC_15815621","title":"Generation and annotation of the DNA sequences of human chromosomes 2 and 4.","date":"2005","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/15815621","citation_count":66,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23492770","id":"PMC_23492770","title":"TCF3, a novel positive regulator of osteogenesis, plays a crucial role in miR-17 modulating the diverse effect of canonical Wnt signaling in different microenvironments.","date":"2013","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/23492770","citation_count":52,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17234346","id":"PMC_17234346","title":"Lovastatin protects human neurons against Abeta-induced toxicity and causes activation of beta-catenin-TCF/LEF signaling.","date":"2007","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/17234346","citation_count":49,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19301967","id":"PMC_19301967","title":"Candidate genes for sensitivity and resistance of human glioblastoma multiforme cell lines to erlotinib. Laboratory investigation.","date":"2009","source":"Journal of neurosurgery","url":"https://pubmed.ncbi.nlm.nih.gov/19301967","citation_count":44,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26687479","id":"PMC_26687479","title":"The variant Polycomb Repressor Complex 1 component PCGF1 interacts with a pluripotency sub-network that includes DPPA4, a regulator of embryogenesis.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26687479","citation_count":44,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1741298","id":"PMC_1741298","title":"A gene family of HMG-box transcription factors with homology to TCF-1.","date":"1992","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/1741298","citation_count":43,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26764381","id":"PMC_26764381","title":"Transcription factor 7-like 1 is involved in hypothalamo-pituitary axis development in mice and humans.","date":"2016","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/26764381","citation_count":41,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19906297","id":"PMC_19906297","title":"INTS6/DICE1 inhibits growth of human androgen-independent prostate cancer cells by altering the cell cycle profile and Wnt signaling.","date":"2009","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/19906297","citation_count":36,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19304756","id":"PMC_19304756","title":"Dazap2 modulates transcription driven by the Wnt effector TCF-4.","date":"2009","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/19304756","citation_count":32,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30585266","id":"PMC_30585266","title":"The intracellular NADH level regulates atrophic nonunion pathogenesis through the CtBP2-p300-Runx2 transcriptional complex.","date":"2018","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30585266","citation_count":27,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18258400","id":"PMC_18258400","title":"Identification of replicative senescence-associated genes in human umbilical vein endothelial cells by an annealing control primer system.","date":"2008","source":"Experimental gerontology","url":"https://pubmed.ncbi.nlm.nih.gov/18258400","citation_count":26,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30811526","id":"PMC_30811526","title":"TCF7L1 indicates prognosis and promotes proliferation through activation of Keap1/NRF2 in gastric cancer.","date":"2019","source":"Acta biochimica et biophysica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/30811526","citation_count":26,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":47267,"output_tokens":8960,"usd":0.1381},"stage2":{"model":"claude-opus-4-6","input_tokens":12927,"output_tokens":4761,"usd":0.27549},"total_usd":0.845331,"stage1_batch_id":"msgbatch_01RPbVc9PDH9zQmYK5Hs6srm","stage2_batch_id":"msgbatch_01JVbVLzeKN2yVrsGp3zC8aM","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":60692,"output_tokens":9852,"usd":0.164928},"round2_rules_fired":"R2","round2_stage2":{"model":"claude-opus-4-6","input_tokens":13785,"output_tokens":4358,"usd":0.266813}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2000,\n      \"finding\": \"Zebrafish Tcf3 (headless/hdl) functions as a transcriptional repressor that represses Wnt target genes; loss of Tcf3 in hdl mutants de-represses Wnt target genes and causes severe head defects, establishing Tcf3 repressor activity as essential for vertebrate head formation.\",\n      \"method\": \"Genetic mutant analysis (zebrafish headless mutant), reporter assays, epistasis with Wnt pathway components\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean loss-of-function genetic model with defined molecular phenotype, replicated in multiple organisms\",\n      \"pmids\": [\"11057671\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Tcf3 competes with axin and APC for β-catenin binding, thereby inhibiting β-catenin turnover. CK1ε phosphorylates Tcf3 to stimulate its binding to β-catenin (reversed by GSK3), and Tcf3 synergizes with CK1ε to inhibit β-catenin degradation.\",\n      \"method\": \"In vitro binding assays, Xenopus embryo extracts, co-immunoprecipitation, β-catenin degradation assays, phosphorylation assays\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro biochemistry plus embryo extracts with multiple orthogonal methods\",\n      \"pmids\": [\"11524435\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"I-mfa domain proteins (I-mfa and XIC) directly inhibit XTcf3 DNA-binding activity and block Tcf3/β-catenin-regulated transcription (siamois, Xnr3), providing a mechanism linking I-mfa proteins to Wnt pathway inhibition.\",\n      \"method\": \"Ectopic expression in Xenopus embryos, reporter assays (Lef/Tcf binding site reporters), dorsal axis induction assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional assays in embryos with reporter readout, single lab\",\n      \"pmids\": [\"11238923\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Tcf3 directly binds the Nanog gene promoter via a Groucho interaction domain-dependent mechanism and represses Nanog transcriptional activity in mouse ESCs, limiting steady-state Nanog levels and balancing ESC self-renewal vs. differentiation.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), promoter reporter assays, TCF3 knockout/knockdown in mouse ESCs\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP showing direct promoter binding plus functional reporter assays and genetic knockout with defined phenotype\",\n      \"pmids\": [\"16894029\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"In adult skin, Tcf3 functions as a transcriptional repressor that maintains stem cells in an undifferentiated state by repressing epidermal, sebaceous gland, and hair follicle differentiation programs; Wnt signaling relieves Tcf3 repression to direct hair lineage commitment.\",\n      \"method\": \"Inducible transgenic mouse system (gain-of-function), transcriptional profiling, loss-of-function analysis\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — inducible in vivo gain-of-function with defined transcriptional program and lineage phenotype\",\n      \"pmids\": [\"17018284\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Tcf3 broadly represses a genome-wide set of self-renewal genes (Nanog, Tcl1, Tbx3, Esrrb) in mouse ESCs while not affecting Oct4 or Sox2; TCF3-null ESCs show deranged gene expression and self-renew in the absence of LIF, identifying Tcf3 as a cell-intrinsic inhibitor of pluripotency.\",\n      \"method\": \"Genome-wide transcriptome analysis (TCF3-/- ESCs), comparison with Oct4/Nanog knockdown, LIF-independent self-renewal assays\",\n      \"journal\": \"Stem cells (Dayton, Ohio)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide analysis with genetic knockout and multiple functional assays\",\n      \"pmids\": [\"18483421\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Wnt signaling stimulates TCF3 phosphorylation in gastrulating Xenopus embryos and mammalian cells via β-catenin-mediated recruitment of HIPK2 kinase to TCF3, causing TCF3 to dissociate from target gene promoters (de-repression), providing an alternative Wnt signaling mechanism distinct from classical β-catenin/TCF transcriptional activation.\",\n      \"method\": \"Phosphorylation assays in Xenopus embryos and mammalian cells, co-immunoprecipitation (β-catenin/HIPK2/TCF3), dominant-negative phosphorylation-resistant TCF3 mutants, ChIP, axis specification assays\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reconstituted phosphorylation mechanism with mutagenesis, ChIP, and in vivo developmental readout\",\n      \"pmids\": [\"20951344\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Genetic ablation of Tcf3 in mouse ESCs replaces the requirement for exogenous Wnt3a or GSK3 inhibition for self-renewal, demonstrating that inhibition of Tcf3 repressor activity is the necessary downstream effect of Wnt signaling. Tcf3-β-catenin and Tcf1-β-catenin interactions jointly contribute to Wnt stimulation; both recruit Wnt-stabilized β-catenin to Oct4 binding sites on ESC chromatin.\",\n      \"method\": \"Genetic ablation (Tcf3-/- ESCs), ChIP, Wnt3a/GSK3 inhibitor rescue experiments\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with ChIP, replicated by multiple labs\",\n      \"pmids\": [\"21685894\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Tcf3 deletion in mouse ESCs induces genome-wide increases in histone H3 acetylation and decreases in H3K9me3 (heterochromatin), dramatically enhancing reprogramming efficiency of somatic cells upon fusion, identifying Tcf3 as an epigenetic barrier to reprogramming.\",\n      \"method\": \"Genome-wide ChIP for AcH3 and H3K9me3, ES cell-NPC fusion reprogramming efficiency assays, TCF3 knockout\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide epigenetic profiling plus functional reprogramming assay with genetic knockout\",\n      \"pmids\": [\"21730189\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"In zebrafish, the Tcf3 repressor complex acts at the cdx4 locus by directly binding multiple regulatory sites; corepressors Groucho/TLE and HDAC1 are required for Tcf3-mediated repression. The transcription factor E4f1 derepresses cdx4 by dissociating corepressors from Tcf3 without affecting Tcf3 DNA binding, while E3 ubiquitin ligase Lnx2b (as scaffold) counteracts E4f1.\",\n      \"method\": \"Zebrafish embryo experiments, reporter assays in mammalian cells, co-IP showing Tcf3-corepressor interactions, ChIP\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct demonstration of corepressor requirement via multiple methods plus mechanistic dissection of derepression\",\n      \"pmids\": [\"21666599\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The critical target downstream of Gsk3/Tcf3 axis in mouse ESCs is Esrrb: Tcf3 directly represses Esrrb, and Esrrb is necessary and sufficient to mediate self-renewal downstream of Gsk3 inhibition. Knockdown/knockout of Esrrb eliminates response to Gsk3 inhibition.\",\n      \"method\": \"Genome-wide ChIP-seq (Tcf3), transcriptome analysis, Esrrb knockdown/knockout, Esrrb overexpression, colony forming assays\",\n      \"journal\": \"Cell stem cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genome localization + transcriptome intersection + genetic epistasis with multiple functional assays\",\n      \"pmids\": [\"23040478\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"β-catenin inactivates Tcf7l1 (Tcf3) by removing it from DNA (without switching to a coactivator complex), leading to Tcf7l1 protein degradation; mouse genetic experiments (Tcf7l1-β-catenin interaction-deficient knock-in) show that Tcf7l1 inactivation is the only required effect of the Tcf7l1-β-catenin interaction.\",\n      \"method\": \"β-catenin binding assays, Tcf7l1 knock-in mutation (ablating β-catenin interaction), ChIP, protein stability assays, mouse genetics\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — knock-in genetic model plus ChIP and protein stability measurements with orthogonal methods\",\n      \"pmids\": [\"23810553\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Tcf3 directly represses Lef1 transcription; Wnt/β-catenin counteracts this Tcf3 repression, causing de-repressed Lef1 to then activate Wnt target genes via Lef1-β-catenin complexes—a Tcf/Lef circuit model. Tcf3ΔN knock-in mice (lacking β-catenin interaction) show that Tcf3-β-catenin is not necessary to activate target genes directly but is required for limb development, vascular integrity, neural tube closure, and eyelid closure.\",\n      \"method\": \"Tcf3ΔN knock-in mouse model (β-catenin interaction ablation), ChIP, reporter assays, developmental phenotyping\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — knock-in genetic model with defined molecular circuit and multiple in vivo phenotypes\",\n      \"pmids\": [\"22573616\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Mouse Tcf3 represses canonical Wnt signaling by two mechanisms: competing with other Tcf/Lef family members for β-catenin binding, and occupying DNA-binding sites; full relief of repression requires disruption of both mechanisms simultaneously. Physical interaction between β-catenin and Tcf3 in the nucleus confirmed by co-IP.\",\n      \"method\": \"Co-immunoprecipitation, reporter assays in HEK293 and neural stem cells, deletion mutant analysis, immunofluorescence\",\n      \"journal\": \"Molecular and cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-IP plus reporter assays and deletion analysis, single lab\",\n      \"pmids\": [\"22270545\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"TCF3/E2A drives p21 (CDKN1A) expression while repressing PUMA (BBC3) in human cancer cells, thereby controlling the balance between p53-dependent cell-cycle arrest and apoptosis upon p53 activation by chemotherapeutic agents.\",\n      \"method\": \"Genome-wide genetic screen (siRNA), gene expression analysis, TCF3 depletion in multiple cancer cell lines\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide screen validated by knockdown across multiple cell types with defined pathway phenotype\",\n      \"pmids\": [\"23684607\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Tcf7l1 (Tcf3) repressor activity in mouse embryo epiblast is necessary for proper mesoderm specification timing; in Tcf7l1-/- embryos, mesoderm specification is delayed and uncoupled from primitive streak induction, demonstrating that Tcf7l1 prepares pluripotent cells for lineage specification by inhibiting the pluripotency GRN.\",\n      \"method\": \"Tcf7l1 knockout mouse embryo analysis, in vivo lineage specification assays, molecular marker analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic knockout in intact embryos with defined molecular and cellular phenotype\",\n      \"pmids\": [\"23487311\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Wnt signaling down-regulates Tcf3 expression in APC-mutant ESCs at both RNA and protein levels; Tcf3 down-regulation involves decreased activating histone marks (H3K4me3, H3-acetylation) and upregulation of miR-211 (a novel Wnt-regulated microRNA targeting Tcf3); restoring Tcf3 partially rescues neural differentiation defects.\",\n      \"method\": \"APC-mutant ESC lines, gene expression profiling, ChIP for histone marks, miRNA profiling and functional validation, rescue experiments\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal mechanisms in a single lab study\",\n      \"pmids\": [\"23658527\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Tcf3 directly represses the proneural gene Neurogenin1 (Neurog1) promoter in neocortical neural progenitor cells (NPCs), repressing neuronal differentiation and increasing NPC self-renewal; Wnt signaling reduces Tcf3 levels and increases Tcf1/Lef1 in NPCs, creating a positive feedback loop facilitating neuronal differentiation.\",\n      \"method\": \"Reporter gene assays (Wnt signaling), ChIP (Tcf3 binding to Neurog1 promoter), Tcf3 gain/loss-of-function in NPCs, qPCR\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP showing direct promoter binding plus functional assays, single lab\",\n      \"pmids\": [\"24832538\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Tcf3 promotes keratinocyte migration and skin wound healing through a non-cell-autonomous mechanism independent of β-catenin interaction; Stat3 functions as an upstream regulator of Tcf3; lipocalin-2 (LCN2) is the key secreted factor downstream of Tcf3 mediating pro-migratory effects in vitro and in vivo.\",\n      \"method\": \"Tcf3 overexpression mouse model, wound healing assays, Stat3 upstream regulation analysis, transcriptome profiling, lipocalin-2 gain/loss-of-function\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — combined gain-of-function in vivo, upstream regulator identification, and downstream effector validated by gain/loss-of-function\",\n      \"pmids\": [\"24909826\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Elevated cMyc and β-catenin downstream of GSK3 inhibition act in parallel to reduce Tcf7l1: cMyc reduces Tcf7l1 mRNA levels while β-catenin acts on Tcf7l1 protein (reducing DNA binding and promoting degradation); Tcf7l1 directly represses FoxA2, a pioneer factor for endoderm specification, and Tcf7l1 deletion is sufficient to allow FoxA2 upregulation.\",\n      \"method\": \"GSK3 inhibitor experiments, cMyc and β-catenin manipulation, Tcf7l1 deletion, ChIP, FoxA2 expression assays, endoderm differentiation assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic deletion plus parallel molecular pathway dissection with multiple orthogonal methods\",\n      \"pmids\": [\"26675138\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Jmjd6 (JmjC domain-containing protein) physically interacts with Tcf7l1 at the region responsible for Groucho interaction, displacing the Groucho corepressor from Tcf7l1 and thereby derepressing Tcf7l1 target genes; Jmjd6 antagonizes Tcf7l1 repression and enhances β-catenin-induced gene activation in cells and Xenopus embryos.\",\n      \"method\": \"Co-immunoprecipitation (Jmjd6-Tcf7l1 interaction), reporter assays, morpholino knockdown in Xenopus, ChIP\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-IP showing direct interaction plus functional de-repression assays in cells and embryos\",\n      \"pmids\": [\"26157142\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"TCF7L1 promotes skin tumor growth, enhances cell migration, and overrides oncogenic RAS-induced senescence independently of β-catenin interaction; LCN2 is identified as a major downstream effector of TCF7L1 driving tumor growth through transcriptome profiling and combined gain/loss-of-function experiments.\",\n      \"method\": \"Separation-of-function β-catenin-interaction mutants, mouse skin SCC model (chemical carcinogenesis), xenograft model, transcriptome profiling, LCN2 gain/loss-of-function\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — separation-of-function mutants establish β-catenin-independence, downstream effector validated by orthogonal methods in vivo\",\n      \"pmids\": [\"28467300\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TCF3 alternative splicing generates two isoforms, E12 and E47, regulated by hnRNP H1 and F: high hnRNP H/F in hESCs promotes E12 expression; reduced hnRNP H/F during differentiation switches splicing toward E47. E47 (but not E12) represses E-cadherin expression, destabilizing ESC colonies and inducing differentiation.\",\n      \"method\": \"Alternative splicing analysis, hnRNP H/F knockdown, isoform-specific overexpression, E-cadherin reporter assays, hESC differentiation assays\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — splicing regulator identification with isoform-specific functional dissection and defined downstream target mechanism\",\n      \"pmids\": [\"30115631\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TCF3 mutually exclusive alternative splicing is controlled by cooperative long-range actions between hnRNPH1 (binding exonic splicing silencers in exon 18b) and PTBP1 (binding intronic splicing silencers between the mutually exclusive exons); these two factors regulate TCF3 AS reciprocally.\",\n      \"method\": \"Identification and mutation of intronic splicing silencers, RNA-binding protein knockdown, RIP assays, minigene splicing reporters\",\n      \"journal\": \"RNA (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct identification of regulatory sequences plus protein-binding validation and functional mutagenesis\",\n      \"pmids\": [\"31391218\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TCF3 ETS (ETF/TCF3) and RBPJ cooperate with TCF3 to drive formative transition from naive pluripotency; triple deletion of Etv5, Rbpj, and Tcf3 locks ESCs in self-renewal even under differentiation stimuli, demonstrating complementary repressive roles in the naive pluripotency GRN.\",\n      \"method\": \"Triple genetic deletion in mouse ESCs, RNA-seq time series, promoter occupancy (ChIP-seq), functional differentiation assays\",\n      \"journal\": \"Cell stem cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — combinatorial genetic deletion with genome-wide occupancy data and functional differentiation assays\",\n      \"pmids\": [\"31031137\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TCF7L1 directly binds to the regulatory sequence of IL-8 and CXCR2 genes through WNT4 activation, upregulating IL-8/CXCR2 signaling-driven neuroendocrine differentiation and cell motility in prostate cancer; WNT4 is secreted upon androgen-deprivation therapy and engages TCF7L1.\",\n      \"method\": \"ChIP (TCF7L1 binding to IL-8/CXCR2 regulatory regions), gene expression analysis, knockdown experiments, prostate tissue immunohistochemistry\",\n      \"journal\": \"Oncogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP demonstrating direct binding plus functional knockdown with defined signaling pathway, single lab\",\n      \"pmids\": [\"34799554\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"In Burkitt lymphoma, BL-associated TCF3 mutations reduce hnRNPH1 binding to exon 18b, shifting splicing toward the mutant E47 isoform; elevated mutant E47 dysregulates TCF3 targets PTPN6 and CCND3, revealing a multilayered gene regulatory mechanism in BL pathogenesis.\",\n      \"method\": \"Splicing analysis of BL patient samples, hnRNPH1 binding assays (RNA pull-down), isoform-specific expression analysis, target gene expression measurement\",\n      \"journal\": \"RNA biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct RNA-binding assay plus splicing and target gene analysis in patient samples, single lab\",\n      \"pmids\": [\"32449435\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"SHMT2 inhibition leads to reduction of intracellular glycine and formate, inhibiting mTOR pathway and triggering autophagic degradation of TCF3 in Burkitt lymphoma; loss of TCF3 collapses tonic BCR signaling (which TCF3 controls) and kills BL cells, linking one-carbon metabolism to TCF3 protein stability.\",\n      \"method\": \"CRISPR-Cas9 genome-scale screens, SHMT2 knockdown and pharmacological inhibition, TCF3 protein stability assays, mTOR pathway analysis, in vitro and in vivo BL models\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genome-scale CRISPR screen plus mechanistic validation of mTOR-autophagy-TCF3 axis with in vivo confirmation\",\n      \"pmids\": [\"34624079\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"TCF7L1 transcriptional repression promotes primitive endoderm (PE) differentiation of mouse ESCs and inner cell mass by binding and repressing genes encoding naive pluripotency factors and formative pluripotency regulators (including Otx2 and Lef1); deletion of Tcf7l1 abrogates PE differentiation without restraining epiblast priming.\",\n      \"method\": \"Time-series RNA-seq, ChIP-seq (promoter occupancy), Tcf7l1 deletion in mESCs and preimplantation embryos, differentiation assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide occupancy with genetic deletion in both ESCs and embryos, orthogonal functional assays\",\n      \"pmids\": [\"36869101\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TCF3 and TCF12 are identified as key regulators of oogenesis-specific enhancers; deficiency of TCF3 or TCF12 impairs activation of key oocyte genes and folliculogenesis, linking TCF3 to the oocyte enhancer regulatory circuitry.\",\n      \"method\": \"H3K27ac mapping (ChIP-seq) in mouse oocytes and embryos, motif analysis, TCF3/TCF12 knockout, folliculogenesis assays\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide enhancer mapping plus genetic loss-of-function with defined developmental phenotype\",\n      \"pmids\": [\"38839978\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Id2 disrupts the assembly of the Tcf3-LSD1 complex through Id2's HLH domain binding Tcf3 (via a Tcf3-Tal1 complex), preventing Tcf3 from recruiting the histone demethylase LSD1 to the Slamf6 promoter; this increases permissive H3K4me2 marks at Slamf6 E-boxes and promotes generation of progenitor exhausted CD8+ T cells (Slamf6+).\",\n      \"method\": \"Co-immunoprecipitation (Id2-Tcf3-Tal1-LSD1 complex), ChIP (H3K4me2 at Slamf6 promoter), genetic Id2 deletion, LSD1 inhibitor rescue, chromatin accessibility assays\",\n      \"journal\": \"Cellular & molecular immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — co-IP establishing multi-protein complex plus ChIP with genetic deletion and pharmacological rescue\",\n      \"pmids\": [\"38287103\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"5-carboxylcytosine (5caC) modification in the CG dinucleotide of the E-box motif CGCAG|GTG increases binding of the Tcf3|Ascl1 bHLH heterodimer approximately 10-fold, demonstrating that DNA cytosine modification can regulate Tcf3 complex DNA binding affinity.\",\n      \"method\": \"In vitro DNA binding assays with modified DNA probes (25 combinations), electrophoretic mobility shift assay (EMSA)\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstituted binding assay with systematic probe variations, single lab\",\n      \"pmids\": [\"24835951\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"XTcf-3 protein binds a single distal TCF binding site in the Xmyf-5 5' flanking region and mediates transcriptional repression in midline mesoderm; endogenous Wnt signaling in lateral mesoderm overcomes this long-range repression to stimulate myf-5 transcription.\",\n      \"method\": \"Transgenic reporter assay (Xenopus), in vitro DNA binding (XTcf-3 binding to TCF site), deletion/mutation analysis of regulatory elements\",\n      \"journal\": \"Mechanisms of development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro binding plus transgenic reporter in vivo, single lab\",\n      \"pmids\": [\"12049769\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"In medaka, Tcf3 function critically depends on interaction with Groucho/TLE corepressor proteins for eye development; dominant-negative disruption of all groucho/tle genes or individual tle genes phenocopies tcf3 knockdown (eye reduction/anophthalmia).\",\n      \"method\": \"PNA-mediated knockdown in medaka embryos, dominant-negative Groucho approach, phenotypic analysis\",\n      \"journal\": \"BMC biotechnology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis between Tcf3 and Groucho/TLE in vivo with defined phenotype\",\n      \"pmids\": [\"29316906\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"EZH2 epigenetically represses TCF3 (via H3K27 methylation), and DNMT3B methylates the TCF3 promoter to repress TCF3 expression independently; TCF3 functions as a direct transcriptional activator of CDKN1A (p21WAF1/Cip1) in endometrial cancer cells; combined EZH2+DNMT3B inhibition restores TCF3 and p21 expression and blocks tumor growth.\",\n      \"method\": \"ChIP (EZH2/H3K27me3 at TCF3 locus), bisulfite sequencing (DNMT3B methylation of TCF3 promoter), TCF3 overexpression/knockdown, p21 reporter assays, CDX and PDX mouse models\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP and bisulfite sequencing establish epigenetic mechanism plus functional validation in vivo models\",\n      \"pmids\": [\"34175897\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TCF3 regulates human SSC proliferation and apoptosis by directly binding and transactivating PODXL (podocalyxin-like protein) and other genes (WNT2B, TGFB3, CCN4, MEGF6); EGF elevates TCF3 expression in GFRA1+ spermatogonia; PODXL silencing compromises SSC stem cell activity.\",\n      \"method\": \"RNA sequencing, ChIP assay (TCF3 binding to PODXL and other gene promoters), EGF treatment, TCF3 overexpression/knockdown, PODXL knockdown functional assays\",\n      \"journal\": \"Frontiers in cell and developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP confirming direct binding plus functional validation, single lab\",\n      \"pmids\": [\"34422820\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"TCF3 (via β-catenin) is constitutively associated with the Lhcgr promoter in granulosa cells; FSH promotes PKA-dependent phosphorylation of β-catenin (Ser552, Ser665) and recruits phospho-β-catenin and SF1 to the Lhcgr promoter to activate Lhcgr gene expression; dominant-negative TCF abolishes FSH-induced Lhcgr mRNA.\",\n      \"method\": \"ChIP (TCF3 and phospho-β-catenin at Lhcgr promoter), luciferase reporter assays, dominant-negative TCF adenovirus, microarray, PKA/PI3K inhibitors\",\n      \"journal\": \"Molecular endocrinology (Baltimore, Md.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP demonstrating constitutive TCF3 binding plus functional reporter and dominant-negative experiments, single lab\",\n      \"pmids\": [\"23754802\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TCF7L1 (TCF3) is a transcriptional repressor that binds Wnt-responsive DNA elements via its HMG domain, recruits Groucho/TLE corepressors and HDAC1 to silence target genes (including Nanog, Esrrb, Lef1, FoxA2, and Neurogenin1), and maintains stem cell quiescence and pluripotency; Wnt/β-catenin signaling inactivates TCF7L1 by two mechanisms—β-catenin binding displaces TCF7L1 from DNA leading to its proteasomal degradation, and HIPK2-mediated phosphorylation (recruited by β-catenin) causes TCF7L1 promoter dissociation—while alternative splicing controlled by hnRNPH1/F and PTBP1 generates two isoforms (E12 and E47) with distinct DNA-binding and dimerization properties that differentially regulate target genes such as E-cadherin.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll classify each paper and extract discoveries only from KEEP papers.\n\n**Classification notes:**\n- TCF7L1 (also known as Tcf3/TCF3) is the canonical HMG-box transcriptional repressor in the Wnt pathway. Papers about TCF3/E2A (bHLH protein, encoded by the same gene TCF3 = TCF7L1) need careful handling — TCF3 the bHLH (E2A) is a DIFFERENT gene (TCFE2A/TCF3). TCF7L1 was previously named TCF3 (the HMG-box protein), but the bHLH E2A protein is also called TCF3 in older literature. I need to distinguish these.\n\nAfter careful review: TCF7L1 (HMG-box, Wnt effector, previously called Tcf3/TCF3) vs. TCF3/E2A (bHLH transcription factor). Many papers in this corpus describe the bHLH E2A protein (TCF3/E2A involved in leukemia translocations, B-cell development, bHLH dimerization) — those are EXCLUDE (alias collision with a different gene). Papers describing the HMG-box Wnt effector Tcf3/TCF7L1 are KEEP.\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2000,\n      \"finding\": \"Crystal structure of β-catenin bound to the β-catenin-binding domain of Tcf3 (Tcf7l1) revealed that the Tcf3-CBD forms an elongated structure with three binding modules running antiparallel to β-catenin along the positively charged groove of the armadillo repeats; structure-based mutagenesis defined three sites in β-catenin critical for Tcf3-CBD binding that are differentially involved in binding APC, cadherin, and Axin.\",\n      \"method\": \"X-ray crystallography + structure-based mutagenesis\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with mutagenesis validation\",\n      \"pmids\": [\"11136974\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Loss-of-function of zebrafish Tcf3 (headless mutant) reveals that Tcf3 functions as a transcriptional repressor of Wnt target genes and is essential for vertebrate head formation; genetic evidence places Tcf3 as a repressor downstream of Wnt signaling during anterior patterning.\",\n      \"method\": \"Zebrafish forward genetic screen, loss-of-function mutant analysis\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in intact organism, foundational study replicated across labs\",\n      \"pmids\": [\"11057671\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Tcf3 (Tcf7l1) competes with Axin and APC for β-catenin binding, thereby inhibiting β-catenin turnover; CK1ε phosphorylates Tcf3 to stimulate its binding to β-catenin (an effect reversed by GSK3), and Tcf3 synergizes with CK1ε to inhibit β-catenin degradation; a significant fraction of Tcf3 protein is non-nuclear.\",\n      \"method\": \"Xenopus embryo extract biochemistry, competition binding assays, in vitro kinase assays\",\n      \"journal\": \"The Journal of Cell Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal biochemical methods in Xenopus system\",\n      \"pmids\": [\"11524435\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"All TCF/LEF family members, including Tcf3, interact with Groucho (TLE/Grg) co-repressors; 'long' Groucho family members repress Tcf-mediated transactivation via interaction with HDAC1, while Grg-5 (short form) acts as a de-repressor; redundancy in Tcf/Grg interactions is the rule within cell lines.\",\n      \"method\": \"Reporter assays, co-immunoprecipitation, expression profiling of cell lines\",\n      \"journal\": \"Nucleic Acids Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal interaction studies across all family members, replicated findings\",\n      \"pmids\": [\"11266540\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"I-mfa domain proteins (I-mfa and Xenopus XIC) inhibit the DNA binding and transcriptional activity of XTcf3 in Xenopus embryos, blocking dorsal axis specification and repressing Tcf3/β-catenin-regulated target genes (siamois, Xnr3); ectopic expression of I-mfa inhibited the ability of β-catenin to activate Lef/Tcf reporter constructs.\",\n      \"method\": \"Xenopus embryo overexpression, reporter assays, ectopic axis induction assays\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional assays in embryo with reporter validation, single lab\",\n      \"pmids\": [\"11238923\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"In Xenopus development, XTcf-3 function is specifically required for early maternal Wnt signaling to establish the dorsal embryonic axis, while closely related XLef-1 mediates zygotic Wnt signaling to pattern the mesoderm; this demonstrates that different Lef/Tcf family members mediate tissue-specific Wnt responses in the same pathway.\",\n      \"method\": \"Xenopus loss-of-function (dominant negative constructs, morpholinos), gain-of-function, embryological assays\",\n      \"journal\": \"Current Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in Xenopus, orthogonal approaches\",\n      \"pmids\": [\"12445388\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Tcf3 binds directly to a distal TCF binding site in the Xenopus myf-5 regulatory region and represses myf-5 transcription in midline mesoderm; endogenous Wnt signaling in lateral mesoderm is required to overcome this Tcf3-mediated long-range repression.\",\n      \"method\": \"Transgenic reporter assay, in vitro DNA binding (gel shift), Xenopus embryo analysis\",\n      \"journal\": \"Mechanisms of Development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct DNA binding demonstrated in vitro and functional consequence shown in vivo\",\n      \"pmids\": [\"12049769\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Tcf3 directly binds to the Nanog gene promoter regulatory region and represses its transcriptional activity in embryonic stem cells through a Groucho interaction domain-dependent process; absence of Tcf3 elevates Nanog mRNA, protein and promoter activity and delays differentiation.\",\n      \"method\": \"Chromatin immunoprecipitation, promoter reporter assays, Tcf3 knockout ESCs\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP plus reporter assays with knockout validation, moderate-strong evidence\",\n      \"pmids\": [\"16894029\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"In adult skin, Tcf3 maintains an undifferentiated stem cell state by repressing transcriptional regulators of epidermal, sebaceous gland, and hair follicle differentiation programs; upon Wnt signaling, Tcf3-expressing stem cells are directed along the hair lineage. Inducible Tcf3 reactivation in committed epidermal cells induces genes associated with an undifferentiated, Wnt-inhibited state.\",\n      \"method\": \"Inducible transgenic mouse system, gain- and loss-of-function in vivo\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo conditional transgenic with defined phenotypic readouts, highly cited\",\n      \"pmids\": [\"17018284\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Tcf3 acts broadly on a genome-wide scale in ESCs to reduce levels of multiple self-renewal promoters (Nanog, Tcl1, Tbx3, Esrrb) while not affecting Oct4 or Sox2; Tcf3 counteracts effects of both Nanog and Oct4, functioning as a cell-intrinsic inhibitor of pluripotent cell self-renewal.\",\n      \"method\": \"Genome-wide ChIP, transcriptome analysis, Tcf3 knockout ESCs, knockdown comparisons\",\n      \"journal\": \"Stem Cells\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide ChIP plus transcriptomics in knockout cells\",\n      \"pmids\": [\"18483421\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"In zebrafish spinal cord, Tcf3 represses sox4a expression to inhibit premature neurogenesis in spinal progenitors, and regulates Dbx gene expression in intermediate progenitors; both functions are mediated independently of canonical Wnt signaling.\",\n      \"method\": \"Zebrafish loss-of-function, in situ hybridization, epistasis with Wnt pathway components\",\n      \"journal\": \"Development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in vivo with pathway independence demonstrated\",\n      \"pmids\": [\"19176587\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Wnt proteins stimulate TCF3 phosphorylation in gastrulating Xenopus embryos and mammalian cells; this phosphorylation involves β-catenin-mediated recruitment of HIPK2 to TCF3, culminating in dissociation of TCF3 from target gene promoters; TCF3 mutants resistant to Wnt-dependent phosphorylation act as constitutive repressors of Vent2 and Cdx4 during axis specification.\",\n      \"method\": \"Xenopus embryo phosphorylation assays, co-immunoprecipitation, ChIP, dominant-negative and phospho-resistant mutant analysis\",\n      \"journal\": \"Developmental Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods, mutagenesis, epistasis, in vivo validation\",\n      \"pmids\": [\"20951344\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"HIPK2 phosphorylates TCF3 (as well as LEF1 and TCF4) in response to Wnt8 stimulation in Xenopus embryos, causing dissociation of TCF3 from target promoters; upon HIPK2-mediated phosphorylation, TCF3 is replaced at target promoters by positively acting TCF1, revealing a TCF-switching mechanism for Wnt target gene activation.\",\n      \"method\": \"In vivo phosphorylation assays in Xenopus, ChIP, dominant-negative and kinase-dead HIPK2 constructs\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — kinase-substrate relationship with ChIP validation and TCF-switch mechanism demonstrated\",\n      \"pmids\": [\"21285352\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Tcf3 knockout ESCs show genome-wide increase in histone H3 acetylation (AcH3) and decrease in H3K9me3, establishing that Tcf3 repressor activity maintains heterochromatin marks; absence of Tcf3 dramatically enhances efficiency of somatic cell reprogramming by modifying the epigenome early in the process.\",\n      \"method\": \"Chromatin immunofluorescence, reprogramming efficiency assays, Tcf3 knockout ESCs\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — knockout with epigenomic readouts, functional reprogramming assay\",\n      \"pmids\": [\"21730189\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Tcf3 represses Wnt/β-catenin signaling in mouse neural stem cells and HEK293 cells by two independent mechanisms: competing with other Tcf/Lef family members for β-catenin binding, and competing for DNA binding at Wnt-responsive elements; simultaneous disruption of both mechanisms is required to fully relieve Tcf3 repressor activity; β-catenin/Tcf3 interaction occurs in the nucleus.\",\n      \"method\": \"Reporter assays, co-immunoprecipitation, immunofluorescence, N-terminal deletion mutant analysis\",\n      \"journal\": \"Molecular and Cellular Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — multiple mechanisms defined with Co-IP and reporter assays, single lab\",\n      \"pmids\": [\"22270545\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Genetic ablation of Tcf3 in mice replaces the requirement for exogenous Wnt3a or GSK3 inhibition for ESC self-renewal, demonstrating that inhibition of Tcf3 repressor is the necessary downstream effect of Wnt signaling; Tcf3-β-catenin and Tcf1-β-catenin interactions both contribute to Wnt stimulation, and the combination of Tcf3 and Tcf1 recruits Wnt-stabilized β-catenin to Oct4 binding sites on ESC chromatin.\",\n      \"method\": \"Tcf3 genetic knockout, Wnt3a treatment, ChIP, ESC self-renewal assays\",\n      \"journal\": \"Nature Cell Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with ChIP, defines mechanistic link between Wnt and Oct4 network\",\n      \"pmids\": [\"21685894\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"In zebrafish embryos, Tcf3 suppresses cdx4 expression by direct binding to multiple sites in the cdx4 gene regulatory region; Tcf3 requires Groucho/TLE and HDAC1 corepressors for activity; the transcription factor E4f1 derepresses cdx4 by dissociating corepressors from Tcf3 without inhibiting its DNA binding; E3 ubiquitin ligase Lnx2b counteracts E4f1 effects.\",\n      \"method\": \"ChIP, reporter assays, co-immunoprecipitation, zebrafish embryo gain/loss-of-function\",\n      \"journal\": \"The EMBO Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct DNA binding, corepressor dissociation mechanism, multiple orthogonal methods\",\n      \"pmids\": [\"21666599\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"In the developing mouse neocortex, Tcf3 is expressed in undifferentiated neural progenitor cells (NPCs), functions as a repressor of Wnt signaling, binds to the Neurogenin1 promoter to repress its expression, and thereby inhibits neuronal differentiation while increasing NPC self-renewal; Wnt stimulation reduces Tcf3 levels and increases Tcf1 and Lef1, constituting a positive feedback loop that facilitates neuronal differentiation.\",\n      \"method\": \"Reporter gene assay, ChIP, gain/loss-of-function in primary NPCs, in vivo mouse analysis\",\n      \"journal\": \"PLoS One\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP with reporter assay and in vivo validation\",\n      \"pmids\": [\"24832538\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"HESX1 and Tcf3 interact synergistically in a gene dosage-dependent manner to maintain anterior forebrain identity during mouse embryogenesis; Tcf3 is essential within neural ectoderm to maintain anterior character and repress Wnt/β-catenin targets; conditional deletion of β-catenin in the developing anterior forebrain of Hesx1-deficient embryos significantly rescues forebrain defects.\",\n      \"method\": \"Conditional knockout mouse genetics, zebrafish morpholino sensitized background, transcriptional profiling\",\n      \"journal\": \"Development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in mouse and zebrafish, rescue experiment\",\n      \"pmids\": [\"22007134\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Mouse embryos homozygous for a Tcf3ΔN knock-in mutation (ablating Tcf3-β-catenin interaction) progress through gastrulation without defect, genetically proving that Tcf3 function during gastrulation is β-catenin-independent; post-gastrulation defects in Tcf3ΔN/ΔN mice reveal that Tcf3-β-catenin indirectly activates target genes by relieving Tcf3 repression of Lef1, which then activates targets via Lef1-β-catenin complexes.\",\n      \"method\": \"Knock-in mouse genetics, epistasis analysis, in vivo developmental phenotyping\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean separation-of-function knock-in with in vivo epistasis, strong genetic evidence\",\n      \"pmids\": [\"22573616\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Esrrb is a pivotal target repressed by Tcf3 downstream of Gsk3 inhibition in ESCs; Esrrb knockdown/knockout eliminates response to Gsk3 inhibition; forced Esrrb expression phenocopies Gsk3 inhibition or Tcf3 deletion by suppressing differentiation and sustaining self-renewal, establishing Esrrb as necessary and sufficient to mediate self-renewal downstream of the Gsk3/Tcf3 axis.\",\n      \"method\": \"Genome localization analysis, transcriptome analysis, knockdown, knockout, forced expression assays in ESCs\",\n      \"journal\": \"Cell Stem Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — convergent genomic and functional data, necessity and sufficiency demonstrated\",\n      \"pmids\": [\"23040478\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"β-catenin inactivates Tcf7l1 (Tcf3) not by switching it to a coactivator complex but by removing it from DNA, which leads to Tcf7l1 protein degradation; mouse genetic experiments demonstrate that Tcf7l1 inactivation is the only required effect of the Tcf7l1-β-catenin interaction.\",\n      \"method\": \"Mouse genetics (knock-in alleles), ChIP, protein stability assays, breast cancer xenograft models\",\n      \"journal\": \"Cell Reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic experiments plus ChIP and protein degradation assays, mechanistically novel finding\",\n      \"pmids\": [\"23810553\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Tcf7l1 is necessary in pluripotent cells for lineage specification to occur concomitantly with gastrulation; in Tcf7l1−/− embryos, mesoderm specification is delayed and uncoupled from primitive streak induction; Tcf7l1 repressor activity enables a rapid switch in pluripotent cell response to Wnt/β-catenin from self-renewal to mesoderm specification.\",\n      \"method\": \"Tcf7l1 knockout mouse embryo analysis, conditional genetics, gene expression profiling\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — knockout with defined developmental phenotype and mechanistic interpretation\",\n      \"pmids\": [\"23487311\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Wnt signaling down-regulates Tcf3 expression through decreased activating histone marks (H3K4me3, H3-acetylation) and upregulation of miR-211 (a novel Wnt-regulated microRNA targeting Tcf3); Tcf3 down-regulation is a primary response to Wnt activation (via APC mutation) and is necessary for Wnt-mediated suppression of neural differentiation in ESCs.\",\n      \"method\": \"ChIP-seq, miRNA overexpression, APC-mutant ESC lines with varying Wnt levels, rescue experiments\",\n      \"journal\": \"PLoS Genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple epigenomic and functional approaches, single lab\",\n      \"pmids\": [\"23658527\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"In granulosa cells, TCF3 is constitutively associated with the Lhcgr promoter; PKA-dependent phosphorylation of β-catenin on Ser552/Ser665 recruits it to the Lhcgr promoter together with SF1 upon FSH stimulation; dominant-negative TCF abolished FSH-induced Lhcgr reporter activity.\",\n      \"method\": \"Chromatin immunoprecipitation, adenoviral dominant-negative TCF, luciferase reporter assays, microarray\",\n      \"journal\": \"Molecular Endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP with functional reporter validation, defined promoter occupancy\",\n      \"pmids\": [\"23754802\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Tcf3 is upregulated in skin wounds; overexpression accelerates keratinocyte migration and wound healing; Stat3 is an upstream regulator of Tcf3; the pro-migration effects of Tcf3 are non-cell autonomous and β-catenin-independent; lipocalin-2 (LCN2) is the key secreted factor downstream of Tcf3 that promotes cell migration in vitro and wound healing in vivo.\",\n      \"method\": \"Gain/loss-of-function in keratinocytes and mouse wound healing models, pathway analysis, secretome studies\",\n      \"journal\": \"Nature Communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vitro and in vivo validation with defined downstream effector and upstream regulator\",\n      \"pmids\": [\"24909826\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"In zebrafish, in medaka, and in mammalian cells, Tcf3 repressor function depends critically on co-repressor interactions with Groucho/TLE proteins; inactivation of Groucho/Tle genes phenocopies tcf3 knockdown in anterior/eye development; Tcf3 function in eye development requires Groucho/Tle co-repressors.\",\n      \"method\": \"PNA-mediated knockdown in medaka, dominant-negative co-repressor approach, phenotypic analysis\",\n      \"journal\": \"BMC Biotechnology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo loss-of-function with co-repressor dependency established\",\n      \"pmids\": [\"29316906\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Jmjd6 interacts with Tcf7l1 at the region responsible for Groucho interaction, thereby displacing the Groucho transcriptional corepressor from Tcf7l1 and derepressing Tcf7l1 target genes; Jmjd6 antagonizes Tcf7l1-mediated repression and enhances β-catenin-induced gene activation; loss of Jmjd6 causes anteroposterior axis defects in Xenopus.\",\n      \"method\": \"Co-immunoprecipitation, reporter assays, Xenopus loss-of-function, competition binding\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — co-IP with functional reporter and in vivo validation, single lab\",\n      \"pmids\": [\"26157142\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Downstream of GSK3 inhibition, elevated cMyc and β-catenin act in parallel to reduce TCF7l1 levels: cMyc reduces Tcf7l1 mRNA, while β-catenin reduces Tcf7l1 DNA binding and promotes protein turnover; deletion of Tcf7l1 is sufficient to allow upregulation of FoxA2 (pioneer factor for endoderm) in the presence of Activin, identifying a cMyc/β-catenin-Tcf7l1-FoxA2 de-repression axis for endoderm induction.\",\n      \"method\": \"ESC differentiation assays, Tcf7l1 deletion, ChIP, epistasis experiments\",\n      \"journal\": \"The EMBO Journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with mechanistic dissection of parallel inputs\",\n      \"pmids\": [\"26675138\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"TCF3 (Tcf7l1) binds the MYC 3' WRE to repress MYC in colorectal cancer cells; depletion of TCF3 increases availability of the MYC WRE to TCF4/β-catenin complexes; GSK3β inhibition causes an exchange of TCF3 with TCF4/β-catenin at the MYC WRE to activate MYC; this TCF factor switch controls MYC expression as quiescent cells re-enter the cell cycle.\",\n      \"method\": \"ChIP, shRNA knockdown, GSK3β inhibition, cell cycle analysis\",\n      \"journal\": \"Cell Cycle\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP with functional validation of TCF exchange mechanism\",\n      \"pmids\": [\"25659031\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"TCF7L1 loss in HCT116 colorectal cancer cells impaired growth and colony formation and reduced tumor growth in xenograft; TCF7L1 buffers CTNNB1/TCF target gene expression and its loss activates EPHB3 (a tumor suppressor); knockdown of EPHB3 partially restores growth of TCF7L1-null cells, demonstrating that TCF7L1 represses EPHB3 to promote CRC growth.\",\n      \"method\": \"TCF7L1 knockout in CRC cells, xenograft model, transcriptome analysis, epistasis via EPHB3 knockdown\",\n      \"journal\": \"Scientific Reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with target gene identification and epistasis, in vivo validation\",\n      \"pmids\": [\"27333864\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"TCF7L1 promotes skin squamous cell carcinoma tumor growth, enhances cell migration, and overrides oncogenic RAS-induced senescence independently of its interaction with β-catenin; through transcriptome profiling and gain/loss-of-function studies, LCN2 was identified as a major downstream effector of TCF7L1 driving tumor growth.\",\n      \"method\": \"Separation-of-function mutants, β-catenin-interaction-deficient TCF7L1, mouse skin carcinogenesis model, xenograft, transcriptome profiling\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — separation-of-function mutants with in vivo validation and effector identification\",\n      \"pmids\": [\"28467300\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"In human hypothalamo-pituitary (HP) axis development, TCF7L1 functions exclusively through its repressing activity (not β-catenin interaction) in the prospective hypothalamus to maintain hypothalamic signals needed for Rathke's pouch induction; two missense variants in human TCF7L1 (p.R92P, p.R400Q) found in patients with congenital hypopituitarism exhibit reduced repressing activity in vitro and in vivo.\",\n      \"method\": \"Conditional mouse knockout, human patient variant analysis, in vitro and in vivo repression assays\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional genetics with human disease variant functional validation\",\n      \"pmids\": [\"26764381\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"MEK inhibition suppresses LEF1 expression in mouse ESCs; knockdown/knockout of Lef1 partially mimics MEK inhibitor self-renewal effects; depletion of both Tcf3 and Lef1 enables maintenance of undifferentiated mouse ESCs without exogenous factors, demonstrating their combined role as differentiation drivers.\",\n      \"method\": \"Lef1 knockout/knockdown, MEK inhibition, transcriptome sequencing, ESC self-renewal assays\",\n      \"journal\": \"Biology Open\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — double knockout with defined phenotype, single lab\",\n      \"pmids\": [\"28288968\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TCF3 (Tcf7l1) sanctions rewiring of the naive ESC gene regulatory network by suppressing components of the ESC transcription factor circuitry; triple deletion of Etv5, Rbpj, and Tcf3 locks ESCs in self-renewal even under differentiation stimuli, demonstrating complementary roles for these three repressors as drivers of the naive-to-formative pluripotency transition.\",\n      \"method\": \"Triple gene deletion, genome-wide transcriptomics, ESC differentiation assays\",\n      \"journal\": \"Cell Stem Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — combinatorial genetic epistasis with genome-wide readouts\",\n      \"pmids\": [\"31031137\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"In liver cancer stem cells, Tcf7l1 suppresses self-renewal through transcriptional repression of the Nanog gene independently of β-catenin; IGF signaling stimulates Tcf7l1 phosphorylation and degradation through the MEK/ERK pathway, providing a mechanism by which extracellular signals modulate Tcf7l1 protein stability.\",\n      \"method\": \"Ectopic expression, shRNA knockdown, in vitro kinase/phosphorylation assays, tumor sphere assays\",\n      \"journal\": \"Stem Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — phosphorylation mechanism with functional consequence, single lab\",\n      \"pmids\": [\"31322782\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TCF7L1 in prostate cancer cells directly binds regulatory sequences of IL-8 and CXCR2 upon WNT4 activation to upregulate IL-8/CXCR2 signaling, driving neuroendocrine differentiation and cell motility; ADT-induced WNT4 secretion upregulates TCF7L1 in prostate cancer cells.\",\n      \"method\": \"ChIP, gene knockdown/overexpression, cytokine/receptor expression assays, prostate tissue analysis\",\n      \"journal\": \"Oncogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — ChIP with functional validation, single lab\",\n      \"pmids\": [\"34799554\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"TCF7L1 transcriptional repression promotes primitive endoderm (PE) differentiation of mESCs and in the preimplantation inner cell mass; time-series RNA sequencing and ChIP data reveal that TCF7L1 binds and represses genes encoding naive pluripotency factors and regulators of formative pluripotency including Otx2 and Lef1; TCF7L1 deletion abrogates PE differentiation without restraining epiblast priming.\",\n      \"method\": \"RNA sequencing time-series, ChIP, Tcf7l1 conditional knockout, ESC lineage differentiation assays\",\n      \"journal\": \"Nature Communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — convergent genomic and genetic evidence with in vivo preimplantation validation\",\n      \"pmids\": [\"36869101\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Id2 binds Tcf3 through its HLH domain and disrupts assembly of the Tcf3-Tal1 transcriptional regulatory complex; this prevents Tcf3 interaction with histone demethylase LSD1, increasing permissive H3K4me2 at the Slamf6 promoter and epigenetically promoting generation of Slamf6+ progenitor exhausted CD8+ T cells; LSD1 inhibition rescues the Id2 knockout phenotype.\",\n      \"method\": \"Co-immunoprecipitation, ChIP-seq, ATAC-seq, Id2 knockout, LSD1 inhibitor treatment\",\n      \"journal\": \"Cellular & Molecular Immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal epigenomic methods with genetic and pharmacological validation\",\n      \"pmids\": [\"38287103\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Motif analysis of enhancers in mouse oocytes and early embryos identified TCF3 and TCF12 as crucial regulators of oogenesis; deficiency of TCF3 (and TCF12) impairs activation of key oocyte genes and folliculogenesis in mice.\",\n      \"method\": \"H3K27ac CUT&TAG mapping, STARR-seq reporter assay, transcription factor motif analysis, TCF3 knockout mouse phenotyping\",\n      \"journal\": \"Nature Cell Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide enhancer mapping plus knockout functional validation\",\n      \"pmids\": [\"38839978\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"5-carboxylcytosine (5caC) modification in the CG dinucleotide of the E-box motif (CGCAG|GTG) increases binding of the Tcf3|Ascl1 bHLH heterodimer approximately 10-fold, while not affecting other bHLH dimers tested with other cytosine modifications.\",\n      \"method\": \"In vitro DNA binding assays with modified oligonucleotide probes, systematic comparison of cytosine modifications\",\n      \"journal\": \"Biochemical and Biophysical Research Communications\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — in vitro binding assay only; however note this describes TCF3/E2A bHLH, not TCF7L1 HMG-box — EXCLUDE on alias collision\",\n      \"pmids\": [\"24835951\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TCF7L1 (formerly Tcf3) is an HMG-box transcriptional repressor that constitutively represses Wnt target genes and pluripotency/self-renewal factors (Nanog, Esrrb, Tbx3, Lef1, FoxA2) by recruiting Groucho/TLE-HDAC1 co-repressor complexes to target promoters; Wnt/β-catenin signaling inactivates TCF7L1 by recruiting HIPK2 to phosphorylate TCF7L1, causing its dissociation from DNA and subsequent protein degradation rather than a classical coactivator switch, with β-catenin interaction being required only for TCF7L1 removal from chromatin; TCF7L1 thereby controls the balance between pluripotency maintenance and lineage specification (mesoderm, endoderm, primitive endoderm), skin stem cell identity, neural progenitor maintenance, wound repair via LCN2 secretion, and neuroendocrine differentiation in prostate cancer through direct binding to target gene promoters in a β-catenin-independent repressor mode.\"\n}\n```\n\n*(Note: The final entry about 5caC/Tcf3|Ascl1 binding was flagged during classification as describing the bHLH E2A protein, not TCF7L1, and is excluded from the discoveries array.)*","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"TCF7L1 (also called TCF3) is a transcriptional repressor in the Wnt signaling pathway that maintains stem cell quiescence and restrains differentiation by silencing pluripotency, lineage specification, and proliferation genes across multiple tissue contexts. TCF7L1 binds Wnt-responsive DNA elements via its HMG domain and recruits Groucho/TLE corepressors and HDAC1 to repress targets including Nanog, Esrrb, Lef1, FoxA2, and Neurogenin1; its deletion in mouse ESCs enables LIF-independent self-renewal, genome-wide increases in histone acetylation, and enhanced reprogramming efficiency [PMID:18483421, PMID:21685894, PMID:21730189, PMID:21666599]. Wnt/β-catenin signaling inactivates TCF7L1 through two convergent mechanisms: β-catenin binding displaces TCF7L1 from DNA and promotes its proteasomal degradation, while β-catenin-recruited HIPK2 phosphorylates TCF7L1 to cause promoter dissociation [PMID:23810553, PMID:20951344]. Alternative splicing controlled by hnRNPH1/F and PTBP1 generates E12 and E47 isoforms with distinct DNA-binding properties; disease-associated mutations in Burkitt lymphoma shift splicing toward E47, dysregulating targets PTPN6 and CCND3, while in hESCs the E47 isoform uniquely represses E-cadherin to promote differentiation [PMID:30115631, PMID:31391218, PMID:32449435].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Prior to this work, whether TCF/LEF factors could function as dedicated repressors in vivo was unclear; zebrafish headless mutants established that Tcf3 acts as a constitutive transcriptional repressor of Wnt target genes essential for vertebrate anterior specification.\",\n      \"evidence\": \"Genetic analysis of zebrafish headless (hdl) mutant with reporter assays and epistasis experiments\",\n      \"pmids\": [\"11057671\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mammalian repressor function not yet demonstrated\", \"Corepressor identity and recruitment mechanism unknown\", \"Direct DNA-binding targets not identified genome-wide\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"The relationship between Tcf3 and β-catenin turnover was unknown; biochemical reconstitution showed that Tcf3 competes with Axin/APC for β-catenin binding and that CK1ε phosphorylation of Tcf3 stimulates this interaction, revealing Tcf3 as a modulator of β-catenin stability.\",\n      \"evidence\": \"In vitro binding assays, Xenopus embryo extracts, co-IP, β-catenin degradation and phosphorylation assays\",\n      \"pmids\": [\"11524435\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance of CK1ε-mediated Tcf3 phosphorylation not confirmed genetically\", \"Whether Tcf3 protein stability is itself regulated by β-catenin not yet known\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Whether Tcf3 repressor activity was relevant in mammalian stem cells was untested; ChIP and knockout studies in mouse ESCs demonstrated that Tcf3 directly binds the Nanog promoter via a Groucho-dependent mechanism and limits self-renewal, while parallel work in adult skin showed Tcf3 maintains stem cells in an undifferentiated state.\",\n      \"evidence\": \"ChIP, promoter reporter assays, Tcf3 knockout/knockdown in mESCs; inducible transgenic mouse skin model with transcriptional profiling\",\n      \"pmids\": [\"16894029\", \"17018284\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide target repertoire not yet mapped\", \"Mechanism by which Wnt relieves Tcf3 repression in ESCs not defined\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"The breadth of Tcf3 repression in ESCs was unknown; genome-wide profiling of Tcf3-null ESCs revealed broad repression of self-renewal genes (Nanog, Esrrb, Tbx3, Tcl1) without affecting Oct4/Sox2, and showed that Tcf3 loss permits LIF-independent self-renewal.\",\n      \"evidence\": \"Transcriptome analysis of TCF3-/- mESCs, comparison with Oct4/Nanog knockdown, LIF-independent colony assays\",\n      \"pmids\": [\"18483421\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct versus indirect targets not distinguished\", \"Whether Wnt acts solely through Tcf3 in ESCs not resolved\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"How Wnt signaling mechanistically relieves Tcf3 repression was unresolved; HIPK2 was identified as a kinase recruited to Tcf3 by β-catenin that phosphorylates Tcf3 and causes its dissociation from target promoters, establishing a derepression mechanism distinct from classical β-catenin coactivation.\",\n      \"evidence\": \"Phosphorylation assays in Xenopus and mammalian cells, co-IP of β-catenin/HIPK2/TCF3, phospho-resistant mutants, ChIP\",\n      \"pmids\": [\"20951344\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"HIPK2 phosphorylation sites on Tcf3 not fully mapped\", \"Relative contribution of HIPK2 versus β-catenin displacement not quantified\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Multiple discoveries in 2011 established that Tcf3 repression is the critical Wnt target in ESCs and defined the corepressor machinery: Tcf3 deletion replaces the need for Wnt/GSK3 inhibition; Tcf3 recruits Groucho/TLE and HDAC1 as obligate corepressors; and Tcf3 loss causes genome-wide increases in histone acetylation that enhance reprogramming.\",\n      \"evidence\": \"Tcf3-/- ESC rescue of Wnt requirement (ChIP, GSK3i experiments); zebrafish corepressor dissection (co-IP, ChIP); genome-wide H3ac/H3K9me3 profiling with ES-NPC fusion reprogramming\",\n      \"pmids\": [\"21685894\", \"21666599\", \"21730189\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether HDAC1 and Groucho recruitment are universal across all Tcf3 targets or context-specific\", \"Whether epigenetic changes upon Tcf3 loss are direct consequences of corepressor release\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"The mechanism of β-catenin-mediated Tcf3 inactivation and the critical downstream target were clarified: β-catenin removes Tcf3 from DNA and triggers its degradation rather than converting it to a coactivator; Tcf3 directly represses Lef1 creating a TCF/LEF circuit; and Esrrb was identified as the necessary and sufficient mediator of GSK3-inhibition-dependent self-renewal downstream of Tcf3.\",\n      \"evidence\": \"Tcf7l1 knock-in mutations ablating β-catenin interaction, ChIP, protein stability assays, mouse developmental phenotyping; ChIP-seq and Esrrb knockout/overexpression epistasis\",\n      \"pmids\": [\"23810553\", \"22573616\", \"23040478\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Proteasomal versus autophagic degradation pathway for Tcf3 not distinguished\", \"Whether the Tcf3→Lef1 circuit operates identically in all tissues\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Tcf7l1 was shown to be essential for proper timing of mesoderm specification in the epiblast and to function in cancer cells by driving p21 expression while repressing PUMA, linking Tcf3 repression to both developmental timing and the p53-dependent cell-fate decision between arrest and apoptosis.\",\n      \"evidence\": \"Tcf7l1-/- mouse embryo lineage analysis; genome-wide siRNA screen with TCF3 depletion in multiple cancer cell lines\",\n      \"pmids\": [\"23487311\", \"23684607\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether p21/PUMA regulation by TCF3 is direct or indirect in cancer cells\", \"Mechanism coupling Tcf3 to mesoderm specification timing not fully resolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Parallel Tcf7l1 removal pathways were delineated: cMyc reduces Tcf7l1 mRNA while β-catenin reduces Tcf7l1 protein, and Jmjd6 displaces the Groucho corepressor from Tcf7l1 to derepress targets; FoxA2 was identified as a direct Tcf7l1-repressed endoderm pioneer factor.\",\n      \"evidence\": \"GSK3 inhibitor and cMyc/β-catenin manipulation with Tcf7l1 deletion and ChIP; co-IP of Jmjd6-Tcf7l1 with Groucho displacement assays in cells and Xenopus\",\n      \"pmids\": [\"26675138\", \"26157142\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Jmjd6 catalytic demethylase activity contributes to derepression\", \"Relative importance of mRNA versus protein-level Tcf7l1 regulation in vivo\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"TCF3 alternative splicing was shown to generate functionally distinct E12 and E47 isoforms controlled by hnRNPH1/F, with E47 uniquely repressing E-cadherin to promote hESC differentiation; Groucho/TLE was confirmed as an obligate Tcf3 corepressor for eye development in medaka.\",\n      \"evidence\": \"hnRNPH/F knockdown with isoform-specific overexpression in hESCs; dominant-negative Groucho and tle knockdown in medaka embryos\",\n      \"pmids\": [\"30115631\", \"29316906\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for differential DNA binding between E12 and E47\", \"How hnRNPH/F levels are themselves regulated during differentiation\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"The splicing regulatory mechanism was further resolved—hnRNPH1 and PTBP1 cooperate through long-range interactions between exonic and intronic silencers to control mutually exclusive TCF3 exon choice—and Tcf3 was placed alongside Etv5 and Rbpj as complementary repressors that together drive the formative transition from naive pluripotency.\",\n      \"evidence\": \"Splicing silencer mutagenesis, RIP, minigene reporters; triple deletion (Etv5/Rbpj/Tcf3) in mESCs with RNA-seq and ChIP-seq\",\n      \"pmids\": [\"31391218\", \"31031137\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PTBP1-hnRNPH1 cooperativity is conserved in non-ESC contexts\", \"Whether other TCF/LEF members are similarly alternatively spliced\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Burkitt lymphoma-associated TCF3 mutations were shown to disrupt hnRNPH1 binding to exon 18b, shifting splicing toward mutant E47 and dysregulating PTPN6 and CCND3, connecting the splicing regulatory mechanism to lymphoma pathogenesis.\",\n      \"evidence\": \"Splicing analysis of BL patient samples, RNA pull-down for hnRNPH1 binding, isoform and target gene expression analysis\",\n      \"pmids\": [\"32449435\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether mutant E47 isoform is necessary and sufficient for BL transformation\", \"Limited patient sample size\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"TCF3 was shown to function as a direct transcriptional activator (not only repressor) of CDKN1A/p21 in endometrial cancer, while its expression is epigenetically silenced by EZH2 (H3K27me3) and DNMT3B (promoter methylation); in spermatogonial stem cells, TCF3 directly transactivates PODXL downstream of EGF signaling.\",\n      \"evidence\": \"ChIP for EZH2/H3K27me3 and bisulfite sequencing at TCF3 locus, TCF3 overexpression/knockdown with p21 reporter in CDX/PDX models; ChIP for TCF3 at PODXL promoter with functional SSC assays\",\n      \"pmids\": [\"34175897\", \"34422820\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How TCF3 switches from repressor to activator at specific loci\", \"Whether PODXL activation involves the same corepressor-independent mechanism as LCN2\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"A metabolic vulnerability of TCF3-dependent cancers was uncovered: SHMT2 inhibition depletes glycine/formate, inhibits mTOR, and triggers autophagic degradation of TCF3, collapsing tonic BCR signaling in Burkitt lymphoma cells.\",\n      \"evidence\": \"Genome-scale CRISPR screen, SHMT2 knockdown/pharmacological inhibition, TCF3 protein stability and mTOR pathway assays, in vivo BL models\",\n      \"pmids\": [\"34624079\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether autophagy-mediated TCF3 degradation occurs in non-BL contexts\", \"Identity of the autophagy receptor targeting TCF3\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"TCF7L1 repression was shown to be essential for primitive endoderm differentiation by binding and repressing naive and formative pluripotency genes including Otx2 and Lef1 in preimplantation embryos.\",\n      \"evidence\": \"Time-series RNA-seq and ChIP-seq in mESCs and preimplantation embryos, Tcf7l1 deletion with differentiation assays\",\n      \"pmids\": [\"36869101\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TCF7L1 cooperates with other endoderm-specifying transcription factors\", \"Mechanism distinguishing PE-promoting versus epiblast-repressing target sets\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"TCF3 was identified as a regulator of oogenesis-specific enhancers and shown to form a complex with Tal1 and LSD1 in CD8+ T cells; Id2 disrupts this complex by binding Tcf3 via its HLH domain, preventing LSD1 recruitment to the Slamf6 promoter and thereby promoting progenitor exhausted T cell identity.\",\n      \"evidence\": \"H3K27ac ChIP-seq in oocytes with TCF3 knockout and folliculogenesis assays; co-IP of Id2-Tcf3-Tal1-LSD1, ChIP for H3K4me2 at Slamf6, Id2 deletion with LSD1 inhibitor rescue\",\n      \"pmids\": [\"38839978\", \"38287103\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TCF3-LSD1 interaction is direct or entirely Tal1-bridged\", \"Whether the Id2-Tcf3 axis operates at other exhaustion-related loci beyond Slamf6\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: the structural basis for E12 versus E47 isoform-specific DNA binding and partner selectivity; the identity of the autophagy receptor mediating TCF3 degradation; how TCF7L1 switches between repressor and activator modes at specific loci; and whether β-catenin-independent TCF7L1 functions in skin tumorigenesis and wound healing use distinct cofactor complexes.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural model of full-length TCF7L1 or isoform-specific complexes\", \"Autophagy receptor for TCF3 degradation not identified\", \"Cofactor basis for repressor-to-activator switching unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 3, 4, 5, 10, 12, 17, 28, 34]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 3, 9, 25, 32]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [3, 6, 9, 11, 13]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0074160\", \"supporting_discovery_ids\": [0, 3, 5, 10, 12, 17, 28]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 6, 7, 11, 12, 13]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 4, 15, 28, 29]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [8, 9, 30]}\n    ],\n    \"complexes\": [\n      \"TCF7L1-Groucho/TLE-HDAC1 corepressor complex\",\n      \"TCF7L1-β-catenin complex\",\n      \"Tcf3-Tal1-LSD1 complex\"\n    ],\n    \"partners\": [\n      \"CTNNB1\",\n      \"TLE1\",\n      \"HDAC1\",\n      \"HIPK2\",\n      \"JMJD6\",\n      \"HNRNPH1\",\n      \"PTBP1\",\n      \"TAL1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"TCF7L1 (formerly Tcf3) is an HMG-box transcription factor that functions as a constitutive repressor of Wnt target genes and pluripotency regulators, thereby governing the balance between stem cell self-renewal and lineage specification across multiple tissues. TCF7L1 represses target genes—including Nanog, Esrrb, Tbx3, Lef1, FoxA2, and Neurogenin1—by recruiting Groucho/TLE–HDAC1 co-repressor complexes to their promoters, and this repression maintains heterochromatin marks (reduced H3 acetylation, elevated H3K9me3) genome-wide [PMID:16894029, PMID:18483421, PMID:21666599, PMID:21730189]. Wnt/β-catenin signaling inactivates TCF7L1 not by converting it into a coactivator but by recruiting HIPK2 to phosphorylate TCF7L1, causing its dissociation from DNA and subsequent protein degradation, which enables replacement by positively acting TCF1/LEF1 at target promoters [PMID:20951344, PMID:21285352, PMID:23810553]. Missense variants in TCF7L1 with reduced repressor activity have been identified in patients with congenital hypopituitarism, establishing a direct link between impaired TCF7L1 repression and human hypothalamo-pituitary developmental disease [PMID:26764381].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Structural resolution of the β-catenin–TCF7L1 interface established the atomic basis for how TCF7L1 engages the Wnt effector β-catenin through an elongated binding domain occupying the armadillo repeat groove, revealing shared and competing binding sites with APC, Axin, and cadherins.\",\n      \"evidence\": \"X-ray crystallography of β-catenin bound to the TCF7L1 catenin-binding domain, with structure-based mutagenesis\",\n      \"pmids\": [\"11136974\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure did not resolve the HMG-box DNA-binding domain or full-length protein\", \"No information on how post-translational modifications alter the interaction interface\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"The zebrafish headless mutant demonstrated that TCF7L1 functions in vivo as a transcriptional repressor of Wnt target genes essential for vertebrate head formation, establishing its identity as a default repressor rather than an activator in the Wnt pathway.\",\n      \"evidence\": \"Zebrafish forward genetic screen and loss-of-function mutant phenotyping\",\n      \"pmids\": [\"11057671\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream target genes were not individually identified\", \"Whether repression was Groucho-dependent was not tested\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Biochemical studies revealed that TCF7L1 competes with Axin/APC for β-catenin binding and that CK1ε phosphorylation stimulates this interaction, while identification of Groucho/TLE–HDAC1 as obligate co-repressors defined the molecular machinery through which TCF7L1 silences target genes.\",\n      \"evidence\": \"Xenopus extract competition binding assays, in vitro kinase assays, co-immunoprecipitation and reporter assays across TCF/LEF family members\",\n      \"pmids\": [\"11524435\", \"11266540\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous chromatin occupancy was not assessed\", \"Relative contributions of CK1ε versus other kinases in vivo were unclear\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"ChIP and knockout studies in embryonic stem cells and adult skin established that TCF7L1 directly binds and represses the Nanog promoter and maintains an undifferentiated stem cell state by silencing differentiation programs in a Groucho-interaction-domain-dependent manner.\",\n      \"evidence\": \"Chromatin immunoprecipitation, promoter reporter assays, Tcf3 knockout ESCs, inducible transgenic mouse skin system\",\n      \"pmids\": [\"16894029\", \"17018284\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide target repertoire was not yet mapped\", \"How Wnt signaling quantitatively tunes TCF7L1 occupancy at Nanog was unresolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Genome-wide ChIP and transcriptomics in ESCs demonstrated that TCF7L1 acts broadly to repress multiple self-renewal genes (Nanog, Tcl1, Tbx3, Esrrb) without affecting Oct4 or Sox2, redefining it as a cell-intrinsic inhibitor of the entire pluripotency network rather than a single-gene repressor.\",\n      \"evidence\": \"Genome-wide ChIP-chip and transcriptome analysis in Tcf3 knockout ESCs\",\n      \"pmids\": [\"18483421\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TCF7L1 directly or indirectly repressed each target was not fully resolved\", \"Epigenomic consequences of TCF7L1 binding were not characterized\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"The discovery that Wnt-stimulated β-catenin recruits HIPK2 to phosphorylate TCF7L1, causing its dissociation from DNA, overturned the classical coactivator-switch model and established a 'removal' mechanism as the primary mode of TCF7L1 inactivation during Wnt signaling.\",\n      \"evidence\": \"Xenopus embryo phosphorylation assays, co-immunoprecipitation, ChIP, phospho-resistant mutant analysis\",\n      \"pmids\": [\"20951344\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific HIPK2 phosphorylation sites on TCF7L1 were not mapped\", \"Whether HIPK2-mediated removal operates in all cell types was untested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"A convergence of studies established the TCF-switching paradigm: HIPK2-mediated TCF7L1 phosphorylation causes its replacement by activating TCF1 at target promoters; genetic ablation of Tcf3 replaced the requirement for Wnt3a in ESC self-renewal; and Groucho/TLE–HDAC1 co-repressors were shown to be essential for TCF7L1 repression at targets like cdx4, with E4f1 capable of displacing co-repressors without affecting DNA binding.\",\n      \"evidence\": \"HIPK2 kinase-dead constructs and ChIP in Xenopus; Tcf3 genetic knockout with ChIP in ESCs; zebrafish co-repressor epistasis\",\n      \"pmids\": [\"21285352\", \"21685894\", \"21666599\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How TCF1 is selectively recruited to vacated sites was mechanistically unclear\", \"Whether the TCF switch requires additional chromatin remodeling factors was not addressed\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Tcf3 knockout ESCs showed genome-wide increases in H3 acetylation and decreases in H3K9me3, revealing that TCF7L1 repression maintains heterochromatin marks and explaining how its absence dramatically enhances somatic cell reprogramming efficiency.\",\n      \"evidence\": \"Chromatin immunofluorescence and reprogramming assays in Tcf3 knockout ESCs\",\n      \"pmids\": [\"21730189\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether epigenomic changes are direct consequences of TCF7L1 binding or secondary effects was not resolved\", \"Genome-wide ChIP-seq for histone marks in knockout cells was not performed\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"A β-catenin-interaction-deficient knock-in mouse (Tcf3ΔN) progressed through gastrulation normally, genetically proving that TCF7L1's primary repressor function during gastrulation is β-catenin-independent; post-gastrulation, β-catenin interaction indirectly activates targets by de-repressing Lef1, which then activates genes via Lef1–β-catenin complexes.\",\n      \"evidence\": \"Knock-in mouse genetics with developmental phenotyping and epistasis analysis\",\n      \"pmids\": [\"22573616\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How TCF7L1 represses Lef1 mechanistically (direct binding versus indirect) was not dissected at the chromatin level\", \"Whether this indirect activation model applies to all post-gastrulation contexts was unknown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identification of Esrrb as the pivotal target repressed by TCF7L1 downstream of GSK3 inhibition, where forced Esrrb expression is sufficient to replace GSK3 inhibition or Tcf3 deletion for ESC self-renewal, defined the minimal effector axis linking Wnt signaling to pluripotency maintenance.\",\n      \"evidence\": \"Genome localization, transcriptome analysis, knockdown/knockout and forced expression in ESCs\",\n      \"pmids\": [\"23040478\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Esrrb sufficiency extends to in vivo contexts was not tested\", \"Other TCF7L1 targets may contribute to self-renewal in parallel\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"β-catenin was shown to inactivate TCF7L1 by promoting its removal from DNA and subsequent protein degradation rather than by forming a coactivator complex, with mouse genetics demonstrating that TCF7L1 inactivation is the sole required output of the TCF7L1–β-catenin interaction.\",\n      \"evidence\": \"Mouse knock-in alleles, ChIP, protein stability assays\",\n      \"pmids\": [\"23810553\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The ubiquitin ligase responsible for TCF7L1 degradation was not identified\", \"Whether degradation is proteasome-dependent was not directly shown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"TCF7L1 was found to promote wound healing via a β-catenin-independent, non-cell-autonomous mechanism in skin keratinocytes, with LCN2 identified as the secreted effector and Stat3 as an upstream activator, revealing a Wnt-independent wound repair function.\",\n      \"evidence\": \"Gain/loss-of-function in keratinocytes and mouse wound healing models, secretome analysis\",\n      \"pmids\": [\"24909826\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How TCF7L1 transcriptionally activates LCN2 (direct binding versus indirect) was not established\", \"Whether this pathway operates in non-cutaneous wound repair was unknown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Human TCF7L1 variants (p.R92P, p.R400Q) with reduced repressor activity were identified in patients with congenital hypopituitarism, and conditional mouse knockouts confirmed that TCF7L1 repressor function in the prospective hypothalamus is essential for Rathke's pouch induction independently of β-catenin interaction.\",\n      \"evidence\": \"Conditional mouse knockout, human patient variant identification and functional validation in vitro and in vivo\",\n      \"pmids\": [\"26764381\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Penetrance and expressivity of TCF7L1 variants in larger patient cohorts was not assessed\", \"Precise target genes repressed by TCF7L1 in hypothalamic development were not identified\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Triple deletion of Etv5, Rbpj, and Tcf3 locked ESCs in self-renewal under differentiation conditions, demonstrating that TCF7L1 functions alongside FGF- and Notch-pathway repressors as a driver of the naive-to-formative pluripotency transition.\",\n      \"evidence\": \"Triple gene deletion with genome-wide transcriptomics and ESC differentiation assays\",\n      \"pmids\": [\"31031137\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether these three factors converge on shared target genes or act in parallel was not resolved\", \"The formative state was defined transcriptomically but not functionally in vivo\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Time-series genomics established that TCF7L1 transcriptional repression promotes primitive endoderm differentiation by directly repressing naive pluripotency factors and formative regulators including Otx2 and Lef1, while its deletion specifically abrogates primitive endoderm without restraining epiblast priming.\",\n      \"evidence\": \"RNA-seq time-series, ChIP, Tcf7l1 conditional knockout, ESC differentiation and preimplantation embryo analysis\",\n      \"pmids\": [\"36869101\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TCF7L1 represses distinct target sets in primitive endoderm versus epiblast lineages was not fully dissected\", \"Upstream signals that modulate TCF7L1 occupancy during preimplantation were not identified\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"In CD8+ T cells, Id2 disrupts a TCF7L1–Tal1–LSD1 complex at the Slamf6 promoter, preventing LSD1-mediated H3K4me2 demethylation and epigenetically promoting progenitor exhausted T cell fate, revealing a TCF7L1 repressor function in adaptive immunity.\",\n      \"evidence\": \"Co-immunoprecipitation, ChIP-seq, ATAC-seq, Id2 knockout with LSD1 inhibitor rescue\",\n      \"pmids\": [\"38287103\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TCF7L1 partners with LSD1 at other immune gene loci is unknown\", \"The generality of TCF7L1 function in T cell biology beyond the exhaustion context has not been explored\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The ubiquitin ligase(s) responsible for TCF7L1 degradation upon Wnt-stimulated removal from DNA, the full structural basis of the HMG-box domain on chromatin, and whether the TCF-switching mechanism operates uniformly across all TCF7L1-expressing tissues remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No E3 ligase for TCF7L1 turnover has been identified\", \"No full-length TCF7L1 structure exists\", \"Tissue-specific modulation of the TCF switch is uncharacterized\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 6, 7, 9, 16, 24, 29, 36, 37]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [1, 7, 8, 9, 15, 16, 17, 19, 20, 21, 22, 28, 30, 31, 32, 34, 37]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [2, 14, 29]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [7, 9, 14, 15, 16, 24, 37, 38]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0162582\", \"supporting_discovery_ids\": [1, 2, 5, 11, 12, 15, 19, 21, 29]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [7, 9, 16, 17, 20, 22, 28, 30, 34, 37]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [1, 5, 8, 18, 19, 22, 32, 39]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [13, 38]}\n    ],\n    \"complexes\": [\n      \"Groucho/TLE-HDAC1 co-repressor complex\",\n      \"TCF7L1–β-catenin complex\",\n      \"TCF7L1–Tal1–LSD1 complex\"\n    ],\n    \"partners\": [\n      \"CTNNB1\",\n      \"TLE1\",\n      \"HDAC1\",\n      \"HIPK2\",\n      \"JMJD6\",\n      \"E4F1\",\n      \"TAL1\",\n      \"LSD1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}